TW200538552A - Hybridization-mediated analysis of polymorphisms - Google Patents
Hybridization-mediated analysis of polymorphisms Download PDFInfo
- Publication number
- TW200538552A TW200538552A TW093117905A TW93117905A TW200538552A TW 200538552 A TW200538552 A TW 200538552A TW 093117905 A TW093117905 A TW 093117905A TW 93117905 A TW93117905 A TW 93117905A TW 200538552 A TW200538552 A TW 200538552A
- Authority
- TW
- Taiwan
- Prior art keywords
- amplicon
- probe
- strand
- probes
- complementary
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
200538552 玖、發明說明: 相關申請案200538552 说明 、 Explanation of invention: Related applications
本申請案主張2003年5月15曰所提申的M 請案No. 60/470, 806號之優先權。 曰T 【發明所屬之技術領域與先前技術】 對於突變或多型性(包含CF)的基因組分析的 、 係為“點-潰(dot-blot),,方法。含右許、準方法 s韦的股( strands))的檢體被點在一硝化纖維支持物上,y 突變或多型性的區域相互補的標定探針接觸。該=可入 得可偵測到與固定化的互補標的序列雜交的探針「疋物使 結的標定探針則以清洗的方式移除。在另一種方、而未鍵 種“反向點-潰版(]reverse d〇t — M〇t f〇rmat),,〜^中—一 ㈣探針陣列係連結在—固態支持物上,而後核 欲標的序列的檢體接觸。參見(例如)美::二: 5, 837, 832號。 寻利弟 二種分析突變或多型性的方法均具有明顯的缺點。該 點-潰方法本身為勞力密集。其 也了月匕因為试驗信號的不 正確判頃而得到錯誤的結果,豆 吊疋由自動放射照相所 元成’知加更多的勞力’因為探針必須常常再-標定。在 :國專5’837,832號中所述之方法牽涉一種複雜且昂 貝的晶片上合成募核脊酸陣列,為—種較適詩大規模 (⑽㈣叫的基因組分析,且其對於只需要有限的作探 針數目改變的診斷應用上並不具實用性或成本效益。 200538552 一種可避免許多上述方法相關之問題的適合多樣性 (inul tiplex)分析的試驗方法係使用了微粒的隨機編碼化陣 列,其中該編碼係表示鍵結在其上之寡核苷酸探針分子的 身分。見美國專利申請序號第1 0/204, 799號:利用應用一 特殊隨機微粒陣列的多重分析分子的分析方法 (Multianalyte Molecular Analysis Using Application-Specific Random Particle Arrays),,。該小珠陣列係與由 一患者樣本所產生的經標定之重複子載體(amplic〇ns)接觸 ’然後彳貞測该標定物(若該標定物為一螢光物質,可以光 學方式偵測),而該鍵結的擴增子(amp 1 i c〇n )可用陣列解密 辨識。 在一多樣性雜父分析中(錯誤配對但近似於同源 (homologous)的交互-雜交反應),探針與擴增子可產生錯 誤的陽性信號。因此,該分析需被設計成可降低此類影響 。一些突變與多型性僅在其為同型合子(h〇m〇zyg〇us)時^ 顯著的,因此,為了在此類的案例中具有實用性,該分析 方法必須能夠分辨異型合子和同型合子。同時,在判斷這 些分析結果時,其中對小珠編編碼的方法與分析結果的決 定係經由光學可偵測的方法,該設定在小珠上的編碼可導 致光譜漏損量(spectral leakage),作為試驗信號的辨別 。因此同時須有一可校正該光譜漏損量的方法。 囊性纖維化(“CF”)在高加索人(caucasians)中是一種 最4見的隱性疾病之一,其在美國發生機率為每2〇 〇〇個存 活新生兒中出現1個。在囊性纖維化跨膜傳導調控子 200538552 (transmembrane conductance regulator ; CFTR)基因的突 變與該疾病相關。CFTR突變數量的增加是持續且快速的’ 且至今已經有高於1 000個突變被偵測出。見Kulczycki L. L.等人(2003)在 Am J Med Genet 116:262-67 所發表的 研究。人口研究指出:最常見的囊性纖維化突變(在CFTR 胺基酸序列(定為ΔΡ508)第508位置編碼苯丙氨酸處有3 個核苷酸的缺失)與大約70%的囊性纖維化案例相關聯。該 突變導致上皮細胞氣離子通道對cAMP反應失調(Frizzell R. A.等人(1 986) Science 233:558-560 ; Welsh,Μ· J. (1986) Sience 232:1648-1650 ; Li, M.等人(1988) Nature 331:358-360 ; Quinton, P. M. (1989) Clin Chem. 35:726-730)。在氣管細胞中,該突變導致鐵離子與 體液傳送的不平衡。一般廣泛地認為此造成囊性纖維化病 人中不正常的黏液分泌,且最後導致肺部感染與上皮細胞 傷害。一些突變係與囊性纖維化相關,研究者持續揭露與 該疾病相關的新突變。美國醫藥遺傳大學(The American College of Medical Genetics ’’ACMG”)已經提出族群中最 常見的囊性纖維化-相關性突變的25控制板(panel),特別 是那些中歐猶太人(Ashkenazi Jewish)與非裔美國人 (African-American)族群。對於一般族群之囊性纖維化相 關性突變的多樣性雜交分析將對該控制板進行測試。 目 【發明内容】 概述 200538552 所敘述的是試驗設計與試驗影像校正的方法 性!ί本J文益’有效用於突變與多型性的多樣性基因:選 ^〜目關突變與多型性’係利用探針對的陣列(在— 方面’其:成員可與一特定突變或多型性的對偶基因 I另—成員可與相應的野生型對偶基因互補),該探針係 與經編編碼的微粒(例如:小珠)鍵結,其中該編編可 一 了者的彳木針。在此所揭示的設計方法係用於設計 -針對CF-相關突變的試驗(係藉由雜交中介多樣性分析) ’且在許多病人檢體中廣泛有效,且證明能夠辨識 見的突變’包含在CFTR基因的外顯子(⑽)3、4、5、了、 9、10、11、13、14b、16、18、19、2〇、21 及内含子 (intron)8 、 12 、 19 〇 在雜交反應前,以二個引子放大在基因組樣本中所欲 區域各引子分別與所欲基因的一股配對。在放 驟中所產生的二股,在此任意指定其中一股為“意放義大: (sense)”另一股為“反義股(anti — sense)”。在某些實例中 ,為了後來利用雜交反應的突變分析,其需要選擇意義股 標的股(與意義股探針雜交)或反義股標的股—與反義股探 針雜父。股的選擇可(舉例而言)利用後—pcR消化(如 PCR digestion)磷酸化的股來達成。尤其當牵涉一穩定的 錯誤配對構形(例如G-T鹼基配對)的探針-標的結合(例如 •意義股-楝針/意義股標的雜交反應)可以被避免時,股轉 換(strand switching)是令人滿意的。 同時本發明揭示針對突變與多型性遺傳篩選的探針與 200538552 擴增子選擇的方法 步驟: 該探針與擴增子選擇的方法牽涉下列 提供-單股MP擴增子家族,其中一股係選 而其互補股係定成反義股,言亥MP擴增子包含經放^的基 因組片段,在其上有該基因的突變或多型性; 針對MP擴增子家族的每-成員選擇互補性MP探針; 測試互補的MP探針之間或Mp擴增子家族之間的同源This application claims the priority of M Application No. 60/470, 806 filed on May 15, 2003. [Technical field and prior art to which the invention belongs] For the analysis of mutations or polymorphisms (including CF) in the genome, the method is "dot-blot," which includes the right and quasi-methods. Specimens of strands) are spotted on a nitrocellulose support, and the y mutation or polymorphic region is complementary to the calibration probe. This = can be detected and can be detected with the immobilized complementary target The probe for sequence hybridization "the target calibration probe is removed by washing. On the other side, the unbonded species" reverse point-decompression (] reverse dot-Motfroma) In the middle, a probe array is connected to a solid support, and then the specimens of the sequence to be labeled are contacted. See, for example, U.S .: 2: Secondary: 5, 837, 832. Seeking a profit. Both methods for analyzing mutations or polymorphisms have significant disadvantages. The point-and-break method itself is labor-intensive. It also obtained incorrect results due to incorrect test signal test signals. Beans are used in automatic radiography to "know more labor" because probes must often be re-calibrated. The method described in: National Patent No. 5'837,832 involves the synthesis of a nuclear and spinal acid array on a complex and Amber wafer, which is a more poetic large-scale (howling genomic analysis, and it requires only limited The diagnostic application for changing the number of probes is not practical or cost-effective. 200538552 A test method suitable for inul tiplex analysis that avoids many of the problems associated with the above methods uses a random coded array of microparticles, The code indicates the identity of the oligonucleotide probe molecule bound to it. See US Patent Application Serial No. 10/204, 799: Analytical method using multiple analysis molecules using a special random particle array ( Multianalyte Molecular Analysis Using Application-Specific Random Particle Arrays). The bead array is contacted with a calibrated repeating subcarriers (amplicons) generated from a patient sample, and then the calibration object (if the The calibration substance is a fluorescent substance, which can be detected optically), and the bonded amplicon (amp 1 icON) can be identified by array decryption. In a heterogeneous heterogeneous analysis (mismatched but nearly homologous cross-hybridization), probes and amplicons can produce false positive signals. Therefore, the analysis needs to be designed to reduce Such effects. Some mutations and polymorphisms are significant only when they are homozygous (h〇m〇zyg〇us) ^ Therefore, in order to be useful in such cases, the analysis method must be able to distinguish the heterotype Zygotes and homozygotes. At the same time, when judging these analysis results, the method of encoding the beads and the analysis result are determined by optically detectable methods. The encoding set on the beads can cause spectral leakage. (Spectral leakage), as the identification of the test signal. Therefore, there must be a method to correct the spectral leakage. Cystic fibrosis ("CF") is the most common hidden disease in the Caucasians. One, it occurs in the United States at a rate of 1 per 2,000 surviving newborns. In the cystic fibrosis transmembrane conductance regulator 200538552 (transmembrane conductance regulator; CFTR) Due to mutations associated with the disease. The increase in the number of CFTR mutations is continuous and rapid 'and to date more than 1,000 mutations have been detected. See Kulczycki LL et al. (2003) in Am J Med Genet 116: 262 -67 published research. Population studies indicate that the most common cystic fibrosis mutation (a deletion of 3 nucleotides at the 508th position encoding phenylalanine in the CFTR amino acid sequence (designated ΔP508)) and Approximately 70% of cystic fibrosis cases are associated. This mutation causes dysregulation of epithelial air ion channels to cAMP (Frizzell RA et al. (1 986) Science 233: 558-560; Welsh, M.J. (1986) Sience 232: 1648-1650; Li, M. et al. (1988) Nature 331: 358-360; Quinton, PM (1989) Clin Chem. 35: 726-730). In tracheal cells, this mutation results in an imbalance between iron ions and body fluid transport. This is widely believed to cause abnormal mucus secretion in patients with cystic fibrosis and ultimately lead to lung infections and epithelial cell damage. Some mutations are associated with cystic fibrosis, and researchers continue to uncover new mutations associated with the disease. The American College of Medical Genetics ("ACMG") has proposed 25 panels of the most common cystic fibrosis-related mutations in the population, especially those of Central European Jews (Ashkenazi Jewish) and non- African-American ethnic group. This control panel will be tested for diversity hybridization analysis of cystic fibrosis-related mutations in general ethnic groups. [Summary of the Invention] Overview 200538552 describes experimental design and experimental images. Methodology of correction! This J Wenyi 'Effective diversity genes for mutation and polymorphism: selection of mutations and polymorphisms' is an array of probe pairs (in-aspects' which: members can With a specific mutation or polymorphism of the dual gene I—the members can be complementary to the corresponding wild-type dual gene), the probe is bound to a microparticle (eg, a bead) encoded by a warp, where the edit can be Alder needles. The design method disclosed here is used to design-test against CF-related mutations (by analyzing the diversity of hybridization intermediaries) 'and in many diseases Extensive and effective mutations in human specimens that have been shown to recognize the mutations included in exons (CF) of the CFTR gene 3, 4, 5, 3, 9, 10, 11, 13, 14b, 16, 18, 19, 20, 21 and introns 8, 12, 19 Before the hybridization reaction, two primers are used to amplify the desired region in the genome sample. Each primer is paired with the desired gene. In the step, The resulting two strands are arbitrarily designated here as "sense" and the other as "anti-sense." In some instances, mutations in order to later use hybridization reactions For analysis, it is necessary to select the stock of the meaning stock (hybridized with the sense stock probe) or the stock of the antisense stock—the heterosexual parent of the antisense stock probe. The selection of the stock can be used, for example, after pcR digestion (such as PCR digestion) to achieve phosphorylated strands. Especially when probe-target binding (such as the hybridization reaction of meaning stock- 楝 needle / significance stock) involving a stable mismatched configuration (eg GT base pairing) can be avoided At the same time, strand switching is satisfactory. The present invention discloses a method for selecting a probe for genetic and genetic mutation screening and 200538552 amplicon selection. The method for selecting a probe and amplicon involves the following provision-single-strand MP amplicon family, one of which is The complementary strand is selected as an antisense strand, and the MP amplicon contains an amplified genomic fragment on which there is a mutation or polymorphism of the gene; it is selected for each member of the MP amplicon family Complementary MP probes; test for homology between complementary MP probes or between Mp amplicon families
將該MP探針分成一組或一組以上的探針組,且將言 MP擴增子分組’使每—組擴增子的成員與_探針組成員; 補,該分組方式係基於避免同源性大於同組探針間或在房 組MP擴增子間的可接受程度; 依—人刼作該每組擴增子,對每組中的每個卯擴增子合 接下來步驟: (a)(i)根據一意義股Mp擴增The MP probe is divided into one or more probe groups, and the MP amplicons are grouped so that members of each group of amplicons and members of the probe group; complement, the grouping method is based on avoidance The homology is greater than the acceptable degree between the probes of the same group or between the MP amplicons of the room group; the human amplicons are used as the amplicons of each group, and each amplicon in each group is combined with the next step : (A) (i) Amplification based on a sense strand Mp
=子互補的探針組之接觸,決定該意義股ΜΡ擴增^ j铋針、且中的其他ΜΡ探針的交互雜交程度是否超過? 叉的程度,如果沒有: 二穴(8)(11)保留在該擴增子組中的該意義股ΜΡ擴增子與 〆k針組中的該互補Mp探針,並對該家族 增子重複進行步驟(a)⑴; 卯擴 • 1)但是如果該交互雜交程度高過該可接受的程度 _ 罙針組中,以該互補反義股MP探針取代該交互 父的MP控4丄 _ 、,十,及在該擴增子組中,以對該反義股MP探針 11 200538552 互補的該反義股MP擴增子取代互補性意義股Mp擴增子, 以及 (b)(ii)重複步驟(a)(i),且假設該交互雜交的程度是 在可接又的耘度内·保留在其各自所屬組中的該反義股好 探針與相對的互補反義股MP擴增子,且重複步驟; (b)(iii)但假設在重複步驟(&)(1)後,該交互雜交的 程度超過該可接受程度:根據該反義股MP擴增子與在任 一組中的該MP探針之接觸,決定該交互雜交的程度是否 在可接受的程度内,假如是,將該與反義股Mp擴增子互 補的反義股MP楝針放置在該組,且將該反義股Mp擴增子 ^置至4互補性反義股Mp擴增子組;但假設根據該針對 每一存在之探針組的決定方法超過交互雜交該可接受的程 度,重複該原始意義股MP探針與互補性意義股Mp擴增子 且放置忒思義股MP探針與該互補性意義股Mp擴增子至 一新的組内,及 (C)在該家族中,對其他意義股做擴增子重複步驟(a) 至(C) 〇 办^同時,本發明揭示一設計探針對的方法(有可分別與一 —又或野生型擴增子互補的成員),該探針係用於與已標 :的擴增子(經由檢體放大反應所產生)和野生型控制組雜 交。針對每—個可預期的變化,成對提供探針,—可與野 生型序列互補’另一與變化型序列互補),該二序列通常 僅具有一個核苷酸不同。一個用以加強多型性雜交中介多 樣性分析(hMAP)可信度的方法係m號的比例(該信號的 12 200538552 產生係因為捕獲標的配對與錯誤配對探針),以及設定可 *頁示正$與異型合子或同型合子變化型的相關數值範圍。 述用表大變及多型性的基因筛選的選擇探針及擴增 子的方法可作為選擇探針對(野生型與變化型)的部分方法 ’再添加下述的方法至前述方法中:The contact of the complementary probe sets determines the MP amplification of the sense strand. ^ Is the degree of cross-hybridization of other MP probes in the bismuth needle more than? The degree of crossover, if not: Two points (8) (11) The significance MP amplicon retained in the amplicon group and the complementary Mp probe in the 针 k-needle group, and the family of amplicons Repeat step (a) ⑴; 卯 Extend • 1) But if the degree of cross-hybridization is higher than the acceptable level _ 罙 Needle group, replace the MP of the cross-parent with the complementary antisense MP probe 4 丄_,, Ten, and in the amplicon set, the antisense strand MP amplicon complementary to the antisense strand MP probe 11 200538552 replaces the complementary sense strand Mp amplicon, and (b) ( ii) Repeat steps (a) and (i), assuming that the degree of cross-hybridization is within reachability. The antisense stock good probes and relative complementary antisense stocks retained in their respective groups MP amplicons, and repeating the steps; (b) (iii) but assuming that after repeating steps (&) (1), the degree of cross-hybridization exceeds the acceptable level: according to the antisense MP amplicons and The contact of the MP probe in any group determines whether the degree of cross-hybridization is acceptable, and if so, the complement of the antisense strand Mp amplicon is complementary. The sense strand MP needle is placed in this group, and the antisense strand Mp amplicon ^ is set to the 4 complementary antisense strand Mp amplicon group; but it is assumed that according to the determination method for each existing probe set Beyond the acceptable level of cross-hybridization, repeat the original sense stock MP probe and the complementary sense stock Mp amplicon and place the Sisi stock MP probe and the complementary sense stock Mp amplicon into a new group And (C) in this family, repeat steps (a) to (C) for amplicons of other meaningful strands. At the same time, the present invention discloses a method for designing a probe pair (there is a Or wild-type amplicon complementary members), this probe is used to hybridize with the labeled amplicon (produced by the amplification reaction of the sample) and the wild-type control group. For each predictable change, the probes are provided in pairs, which can be complementary to the wild-type sequence '(the other is complementary to the variable sequence), and the two sequences usually differ by only one nucleotide. A method to enhance the credibility of the polymorphic hybrid intermediary diversity analysis (hMAP) is the proportion of m number (12 200538552 of this signal is generated because of the capture of the target pair and the mismatched probe), and the setting can be shown on the page The range of values associated with positive $ and heterozygous or homozygous variants. The method of selecting probes and amplicons for gene screening using polymorphism and polymorphism can be described as part of the method for selecting probe pairs (wild type and variant type). 'Add the following method to the aforementioned method:
提供—單股wt擴增子的家族,其中一股係經選定為意 義股與該互補股係經敎為反義股,該家族各自表現一男 f型基因、组的放大部&,且相對於基因組的每一個該放太 部分,其在當MP擴增子的家族產生時被放大; 提供及選擇-意義股或一反義股WT探針,以便在相同 中同時擁有一意義股WT探針與一相對的意義股如 :―’或在—相同的探針組中同時擁有一反義股訂探針 人一相對的反義股MP探針; 伏疋:(i)在一探針 π,日丁丹一; 二針之間的交互雜交的程度’與在一探針組中的一打Provide—A family of single-strand wt amplicons, in which one strand is selected as a sense strand and the complementary strand is warped as an antisense strand. Each of these families expresses a male f-type gene, an amplified portion of the group & For each part of the genome that is amplified, it is amplified when a family of MP amplicons is produced; provision and selection of a sense strand or an antisense strand WT probe to have a sense strand WT probe at the same time Needle and a relative sense unit such as: ― 'or in the same probe set at the same time have an antisense stock subscription probe person an opposite antisense stock MP probe; Fu Xi: (i) a probe π, Zintandan I; the degree of cross-hybridization between two needles' and one dozen in a probe set
二與—相料MP探針之間的交互雜交程度,是否起 範圍,如果是,(⑴假設將選擇之意義股或反 月up及WT探針替換為互補性_ Mp_ > mu 二程:是否將落入在可接受範圍内;(ιιι)決定該互補 ,探針與在相同探針組中可與其他成員互補的擴 二互雜交是否將超過可接受程度,且假設為是,。 探互㈣WT及ΜΡ探針放至另_探針組中,在相 出可二:二其他成貝互補的擴增子之交互雜交是否將 又的程度,且假設為否,將該互補η及ΜΡ探針 13 200538552 在該探針組中;作咖< —假政為疋,(V)對每一存在的探針組重複 步騎A ( 1 V ),且假兮令叙 . 又口又母一存在的探針組超出該接受程度,則 將該互補WT及MP控# # s ^ iThe degree of cross-hybridization between the two-phase material MP probes, whether it is in range, and if so ((assuming that the selected meaning stock or anti-moon up and WT probes are replaced with complementary _ Mp_ > mu two-way: Whether it will fall within an acceptable range; (ιιι) Determines whether the complementarity, whether the probe and an extended two-hybrid that can be complementary to other members in the same probe set will exceed the acceptable level, and it is assumed to be yes. Mutual WT and MP probes are placed in another probe set, and the degree of cross hybridization between two complementary amplicons of two other shellfish complementary amplicons will be reached again, and if not, the complementary n and MP Probe 13 200538552 In this probe set; make coffee < — fake government as a sham, (V) repeat step A (1 V) for each existing probe set, and falsely order Syria. If the probe set existing on the parent exceeds the acceptance level, the complementary WT and MP control # # s ^ i
,十放至一新組中,且將互補Π及MP 擴知子放至一相應的新組中。 雜又疋相關於在任何分析中牽涉多重雜交,且 可避免在分析結果中不良效應的方法也包含在内。一種用 以杈正在一陣列格式的交互雜交的方法係設定一系列的增 溫條件,選擇使得在每一、、田 牡母 1度下包含特定錯誤配對構形的, Put ten into a new group, and put the complementary Π and MP amplicon into a corresponding new group. Miscellaneous is also related to methods that involve multiple hybridizations in any analysis and that avoid adverse effects in the analysis results. A method of cross-hybridization in an array format is to set a series of temperature increasing conditions, and select the one that contains a specific mismatched configuration at 1 degree per field.
探針-標的複合物會變性的溫度,而包含那些配對的(“互補 驗基對構形者將維持纟#。 订个文…、後偵測雜父到陣列上探針 之經捕獲的標定股所產味的 ^ ^ 屋生的仏唬,並在母一設定的溫度點 、·己錄之“刀析不同信號的演變對溫度的函數可校正超過某 解鏈/皿度日守預期成為不安定狀的每一錯誤配對。當所 有錯誤配對的所有溫声却„中科士 a 吓畀/皿度自又疋點決定後,收集自一較低溫度 的數據可被校正所有的錯誤配對。The temperature at which the probe-target complex will denature, and those that are paired ("Complementary test base pairs will maintain 者 #. Order a text ..., and then detect the heterogeneous parent to capture the calibration of the probe on the array ^ ^ The horror of the house produced, and at the temperature set by the mother, the evolution of the different signals of the "knife analysis" as a function of temperature can be corrected beyond a certain melting point / dish. Unstable every wrong pairing. When all the warm sounds of all wrong pairings have been determined, the data collected from a lower temperature can be corrected for all wrong pairings .
在其他方面,因為在此的分析方法係依賴經編碼的小 珠來鑑認附著於其上的探針,且該編編碼在—具體實例中 係經由染劑染色,試驗信號通常係利用螢光信號標定並除 去背景值所產生。特定而言,本發明揭示一校正分析影像 的方法。即,在選擇來紀錄試驗影像的光譜帶中,可校正 經紀錄的光學特徵組(在試驗中經由標的物抓取小珠-展示 的探針所產生)編碼強度之“光譜漏漏損量(spectrai leakage)”(自該分析影像的該殘餘發射量所得一幾可亂真 貢獻量的來源)的影響,該強度是由低波長的小珠編碼染 14 200538552 劑所釋放。在此提供一試驗設計,其負控制組小珠係包含 在編碼小珠每一形式的隨機編編碼陣列内,該編碼小珠產 生不能接受之大的光譜漏漏損量(例如)對包含不同量的特 定編編碼染劑的小珠。 在此所述的實施例,負控制組小珠展現一 1 8 — mer聚核 苷酸以進行第二用途,即,允許對非專一性吸收效應的試 驗影像的校正。較佳的是,該背景值校正係根據負控制組 小珠的每一型態其隨機位置所建構一背景圖像像,其中負 向控制組小珠的每一該型態係以一預-選擇性的豐富(pre一 selected abundance)包含在該陣列中。對在該陣列中的負 控制組小珠的母一型悲,一背景圖像像係經由位於該型態 的小珠的質量中心,利用標準方法(如第三圖所示;參見 例如Seul,O’Gorman & Sammon,“影像分析的實用演算法 (Practical Algorithms for Image Analysis), “Cambridge University Press,2000;第 222 頁;併入作 為參考資料)建構該相關Voronoi棋盤型,且而後填滿每一 包含一小珠的多邊形,該多邊形具有該強度的小珠可以產 生一圖像像(參見例如第三圖所示的圖像)。視需要地,可 以貫施標準過渡操作方法以使該圖像像平滑;即,平均化 自鄰近的影像值的影響。(參見例如Seul,0,G〇rman & Saminon,“影像分析的實用演算法(Practical Algorithms for Image Analysis), 55 Cambridge University Press, 2 0 0 0對過濾器的描述)。 該圖像在該全部背景值中呈現一有限的檢體,以建構 15 200538552 該分析影像方法,/ ^ . t . 〜方法係記算某些非線性視覺上效果, 為所 冓成的陣列相關,該效果在當該小珠被放 、表面的機械捕捉器時被特別聲明。除此之外, 背景值圖像將顯示出旦 出在4月厅、值中可能升高的非—均一性 牛仞而°自非—均勻的亮度或非—均勻的標的分布或放 、人】珠陣列接觸的分析(analy忱)。用於不同型態的 負控制組圖像,即,包含 ' 匕3不同里的編碼染劑及產生不同程 度的光谱漏損量,"if w ^ 了月b以遠相同平均強度被標準化及以增 加該檢體的速率被加成。 该分析影像可能經由接續利用該背景圖像而校正。在 某些實施例中,該圖像係簡單地自分析影像中去除,用以 產生-校正後的分析影像。在某些具體實例中,該背景值 可以、、、。口平面領域法(flat fielding),,的步驟(參見, 例如· Seul,O’Gorman δ Sammon,“影像分析的實用演算 法(Practice Algorithms for Image Analysis),,, Cambridge University Press,2000)。在這個流程中,該 常數(即,該空間非多變性)成為該背景值圖像的一部分, 且試驗影像被去除,且該經校正的分析影像係經由該校正 的背景圖像分割,以得到一“平面領域法,,強度圖像。 發明詳述 這裡所提供的為一在該囊性纖維化跨膜傳導調控子 (CFTR)基因的選定組(designated set)多型性(hMAp)的多 重分析中介雜交方法。 用於偵測在一標的序列内的突變之探針,與具高親人 16 200538552 力的重複子探舰,當該整個重複子探針或其中 列(subse轉u:e)係為完全與該探針互補(“配對”)時,射 成經選定的標的位置(designated以州We);作是: 與-低親合力的重複子探針雜交時,則具有非完全=田“ 錯誤配對”)區域。通常’本發明的該探針必須足夠長,以 防止與不相關# MA標的序列黏合。在某些具體實:中以 該探針的長度可以為約10纟50個驗基,或較佳的為約Η 至25個鹼基,及更佳的為18至2〇個鹼基。In other respects, because the analytical method here relies on coded beads to identify the probes attached to it, and the code is-in a specific example, stained with a dye, the test signal is usually fluorescent Signal calibration and removal of background values. In particular, the present invention discloses a method for correcting and analyzing images. That is, in the spectral band selected to record the test image, the "spectral leakage amount (the amount of spectral leakage ( spectrai leakage) "(the source of a few distorted contributions from the residual emission of the analysis image), the intensity is released by the low-wavelength bead code 14 200538552 agent. An experimental design is provided here. The negative control set of beads is included in a random coded array of each form of coded beads. The coded beads produce an unacceptably large amount of spectral leakage (for example) containing different A number of beads specifically coded for the dye. In the example described herein, the negative control group beads exhibit an 18-mer polynucleotide for a second use, that is, to allow correction of experimental images of non-specific absorption effects. Preferably, the background value correction is to construct a background image image according to the random position of each type of the negative control group beads, wherein each of the types of the negative control group beads is pre- Selective abundance is included in the array. For the mother type of the negative control group beads in the array, a background image image is passed through the center of mass of the bead located in this type using a standard method (as shown in the third figure; see, for example, Seul, O'Gorman & Sammon, "Practical Algorithms for Image Analysis," "Cambridge University Press, 2000; p. 222; incorporated as reference material" constructs the relevant Voronoi checkerboard pattern and then fills it Each polygon containing a bead, the bead having the intensity of the polygon can produce an image image (see, for example, the image shown in the third figure). Optionally, standard transition operations can be applied to smooth the image; that is, to average the effects from neighboring image values. (See, for example, Seul, 0, Gorman & Saminon, "Practical Algorithms for Image Analysis, 55 Cambridge University Press, 20000 for a description of filters." A limited sample is presented in all background values to construct 15 200538552 The analysis image method, / ^. T. ~ The method calculates some non-linear visual effects, which are related to the resulting array. The bead was placed and the surface of the mechanical catcher was specifically declared. In addition, the background value image will show the non-uniform burdock that may rise in value in April, and since Non-uniform brightness or non-uniform target distribution or placement, analysis of human] bead array contact (analy). Used for different types of negative control group images, that is, the encoding Agents and produce different degrees of spectral leakage, " if w ^ the month b is normalized far more than the same average intensity and is added at a rate that increases the specimen. The analysis image may be corrected by successively using the background image In In the embodiment, the image is simply removed from the analysis image to generate a corrected analysis image. In some specific examples, the background value may be, flat field method, (See, eg, Seul, O'Gorman δ Sammon, "Practice Algorithms for Image Analysis," Cambridge University Press, 2000). In this process, the constant (that is, the spatial non-variability) becomes a part of the background value image, the test image is removed, and the corrected analysis image is segmented via the corrected background image to obtain A "planar field method, intensity image. Detailed description of the invention Provided herein is a multiplexing of a designed set polymorphism (hMAp) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Analyze intermediary hybridization methods. Probes used to detect mutations in a target sequence, and repeater probes with high relatives 16 200538552 power, when the entire repeater probe or one of its repeaters (subseed u: e) When it is completely complementary ("paired") with the probe, it is shot to the selected target position (designated with state We); As a result: when it hybridizes with-low affinity repeater probe, it has incomplete = "Mistaken pairing") region. In general, the probe of the present invention must be long enough to prevent sticking to unrelated #MA target sequences. In some specific embodiments, the length of the probe can be about 10 纟 50 Test basis, or preferably about Η to 25 bases, and more preferably 18 to 20 bases.
探針係利用連接體一部份(linker moieties)以既有技 術中已知的方法經由其個㈣5,端的黏㈣編編碼的微粒 (小珠)上,編碼該微粒具有一化學或物理上可分辨的特 性可獨特的鑑認黏附的探針。探針係被設計成可抓取所欲 的標的序列’該序列包含在與小珠接觸的溶液中。雜交至: 展示在特定小珠上之探針的標的物會產生一光學可偵=的 信號。每個參與的小珠的光學信號獨特地對應於表現在該 小珠上的探針。該雜交步驟之前或接續步驟,操作者可利 用微粒鑑別法及偵測法(例如利用去編碼化(dec〇ding)或利 用多重顏色的螢光顯微鏡)判斷該探針的身分,。 該小珠的成分包含(但不限於)塑膠、陶、玻璃、聚苯 乙烯、曱基苯乙烯、丙烯酸聚合物、順磁性材料、氧化钍 月爹體(thoria sol)、碳石墨、二氧化鈦、乳膠或交鏈的葡 萄聚糖(例如交聯葡萄糖(sepharose))、纖維素、尼龍、交 鏈膠質微粒及鐵氟龍。參見由Bangs Ub〇rat()ries,Probes use linker moieties to encode microparticles (beads) coded by the glutamate on the 5 'end of the linker moieties in a known manner. The microparticles encode a chemically or physically The resolving properties uniquely identify the attached probe. The probe system is designed to capture a desired target sequence 'which is contained in a solution in contact with the beads. Hybridize to: The target of the probe displayed on a particular bead will produce an optically detectable signal. The optical signal of each participating bead uniquely corresponds to the probe displayed on the bead. Before or after the hybridization step, the operator can determine the identity of the probe using particle identification and detection methods (for example, using decoding or multi-color fluorescence microscopy). The composition of the beads includes (but is not limited to) plastic, ceramic, glass, polystyrene, fluorenyl styrene, acrylic polymer, paramagnetic material, thoria sol, carbon graphite, titanium dioxide, latex Or cross-linked glycan (such as sepharose), cellulose, nylon, cross-linked colloidal particles, and Teflon. See by Bangs Ub〇rat () ries,
Fisher IN 的 “Microsphere Detection Guide,,。該微粒不 17 200538552 需要為球形且可為玄 如]_至毫十(=性 的大小可自奈米(例 ”(]如· lmm)的範圍,較佳的是該小珠係 R^勺〇·^米至約2GG微米,更佳的是為約Q· 5微米至約 5微米係尤其較佳者。 :某些具體實例中,小珠可以在雜交步驟之前排列在 土為上成-平面陣列。小珠也可裝載在一平面基質上以 在雜交步驟後的成像。在此處的流程及系統提供一高 ^力刀析%式’允許全部陣列小珠立即顯像,及同時進行 夕重病人檢體的基因分析。 小珠陣列可以為一隨機編碼化編碼陣 =的編碼(放置在該陣列内並未事先知曉的位置= 者们珠上的该募核穿酸的探針身分。隨機編碼化陣列 可以根據揭示在國際申請案第PCT職/2〇179號(在此併 入作為參考)中㈣之該方法與流程來進#。 該小珠陣列可利用分散整批處理製造出適用特殊性的 (卿ilcatl〇n-speciflc)基質(例如:晶圓規格的晶片), 而製造出具有化學編碼及附著於寡核苦酸探針的小珠(例 :規格約每刚"懸浮液1()8個小珠)。這些小珠係與受 :結合(例如·’矽晶片)及在一經選定的基質區域形成一緻 植的陣列。在某些具體實例中,該包含4_自3 ^小 珠的小珠陣列尺寸為300 "乘3〇〇" m。使用不同大小的 小珠則密度會改變。多重小珠陣列也可以同時 上之分離的液態區劃中形成。該種方法係在美國專利二 號弟ig/i 92,352號中揭示,名稱為“微微粒陣列與其製^ 18 200538552 方法’’,在此併入作為參考。小珠陣列可以‘‘leapstm,,的方 法形成,如美國專利第6,251,691 、6,514,771 、 6, 468, 81 1號所述,併入作為參考。 在本發明中所使用的基質(例如:晶片)可為一種平面 電極的模式(patterned),與LEAPS之界面模組化 (interfacial patterning)方法一致,其係藉由(例如)氧 化物或其他電介質物質的模式生長(patterned gr()wth), 在供應AC電場下產生所欲之抗阻梯度的結構。模式 (patterns)可以被設計來產生想要的aC域-誘發液流構形 以及相關的微粒傳送。基質可以利用半導體製程技術被模 組化成晶圓規模。除此之外,受質可以利用放置一種— 可刻劃、可透光聚合物的薄膜來劃分之,固定在基質上一 所欲之液態導管與區塊佈局,使液體限制在一個或數個分 離的區塊内,因此在一所提供的基質上可容納多重檢體。77 罘一 平面型電極而製備,^Fisher IN's "Microsphere Detection Guide." The particles do not need to be spherical and can be Xuanru] _ to milliseconds (= the size of sex can be in the range of nanometers (eg) (] such as · lmm), compared to Preferably, the beads are from R ^ spoon to about 2GG microns, and more preferably from about Q.5 microns to about 5 microns. In some specific examples, the beads may be Arranged on the soil before the hybridization step into a planar array. Beads can also be loaded on a planar substrate for imaging after the hybridization step. The process and system here provides a high-powered analysis method that allows all The array beads are immediately visualized, and the genetic analysis of the patient's specimen is performed at the same time. The bead array can be a random coded coding array = code (placed in a position in the array that is not known in advance = the beads). The identity of the probe for collecting nuclear and acid. The random coded array can be entered according to the methods and procedures disclosed in International Application No. PCT No./201079 (herein incorporated by reference). Bead arrays can be manufactured using discrete batch processing ( Qing ilcatlón-speciflc) substrate (for example: wafer-specific wafers), and beads with a chemical code and attached to an oligonucleotide probe (eg, about 1 in each specification &suspension; 1) 8 beads). These beads are bound to the substrate (eg, silicon wafers) and form a uniformly implanted array in a selected matrix region. In some specific examples, the The size of the bead array of beads is 300 " by 300 " m. The density will change with the use of beads of different sizes. Multiple bead arrays can also be formed in separate liquid zones at the same time. This method is based on U.S. Patent No. 2 ig / i 92,352 discloses that the name is "microparticle array and its method" 18 200538552, which is incorporated herein by reference. Bead arrays can be formed by the method "leapstm", such as the United States Patent Nos. 6,251,691, 6,514,771, 6, 468, 81 are incorporated by reference. The substrate (eg, wafer) used in the present invention may be a mode of a planar electrode ( patterned), modularization of the interface with LEAPS (interfacial patternin g) The method is consistent. It is a patterned growth (for example) of oxide or other dielectric substances (patterned gr () wth), which produces the desired resistance gradient structure under the supply of AC electric field. The patterns can be Designed to produce the desired aC domain-induced flow configuration and associated particle transport. The substrate can be modularized to wafer scale using semiconductor process technology. In addition, substrates can be placed using one—scribing, Divided by a light-transmissive polymer film, fixed on the substrate with a desired liquid conduit and block layout, so that the liquid is confined to one or several separate blocks, so it can be accommodated on a provided substrate Multiple specimens. 77 罘 一 Planar electrode, ^
該小珠陣列可利用提供The bead array is available to provide
電極係實質上平行一第二電極(“三明治,,狀),有二個電4 被-間隙(gap)所分隔’且内含一可極性化的液體培養液 例如-種電解質水溶液。該第二平面型電極的表面或内名 可用界面模組化(interfaeial patterning)的方法來^ 化。該小珠被導入該間隙内。當對該間隙供應一交流電, 壓時,該小珠在該第二電極(例如·曰The electrode system is substantially parallel to a second electrode ("sandwich,"), has two electric electrodes separated by a gap, and contains a polarizable liquid culture medium such as an aqueous electrolyte solution. The surface or internal name of the two planar electrodes can be changed by interfaeial patterning. The beads are introduced into the gap. When an alternating current is applied to the gap, the beads are in the first place. Two electrodes (such as
、〗如·日日片)形成一隨機編石I 化陣列。且,也利用LEAPS’可在光敏感型電極(“晶片” 上形成小珠陣列。較佳的是,上述的三明治狀配置也使用 一平面光敏感型電極及其他平面型電極。再一次,該二 19 200538552 極係以一間隙分隔,且包含一電解質水溶液。將一功能化 且經編碼的小珠導入該間隙中。使用AC電壓及光線,該 小珠在該光敏感型電極上形成一陣列。 在某些具體實例中,小珠可具有一化學的光學可分辨 的特徵。舉例而言,其達成可藉由使用一些光學可分辨之 標籤來染色小珠,該標籤例如那些包含一種或一種以上光 碏可分辨其激發波長、放射波長、激發態生命期或放射強 度的螢光或發色團染劑。製作該光學可分辨的標籤可以特 疋比例用於將小珠染色,舉例而言,如在Fulwyler美國專 利第4, 71 7, 655 (1 988年1月5日)中所述。染色也可使用 該項技術者所熟習的方法增大微粒來達成,見(M〇lday, Dreyer, Rembaum & Yen, J. Mol Bio 64, 75-88 (1975) ,L· Bangs,‘均勻乳膠微粒(uniform iatex particles), Sergen Diagnostics,1 984)。舉例而言,多至12種形式 的小珠是用利用二種顏色增大(swell)及大塊(bulk)染色來 編碼,每一種分別在四個強度分級内,且混合在四個名義 上的莫耳比例内。或者,該組合顏色的編碼化方法(詳述 於國際申請案PCT/US第98/1〇719號中,在併入作為參考 文獻)可用於賦予該小珠陣列光學可分辨地標籤。除了化 學編碼化,小珠也可以利用詳述於國際申請案第 WO/01 /098765號中的方法而具有磁性。 除了染劑的化學編碼,具有某些募核苷酸引子的小珠 也可以被空間分隔(“空間編碼化(spatial encoding)”), 使得小珠的位置提供了 一些放置其中之小珠身分的資訊。 20 200538552 舉例而έ ’空間編碼化 了在陣歹j、、且裝的過程中於一 中完成,,其係藉由使用ί}?Αρς * 4丄上 ,夜相 用LEAPS末針對變化的電場中 根據投射於基質的光握+ t穷中及/或 之結構)。^ μ式來組裝平w料列(任何所欲 LEAPS切晶片與液體之間的界面阻抗產生橫向梯度 ’用以緩和中介陣列組合之電流體力學的力。t的要求是 適度的:於液態間隙(通常兩個平面電極間為10Mm)施用 典型上低⑥l〇Vpp的低交流電壓。此種組合流程是快速的 且是可光學程控的(optically pr〇grammable) ·•包含數千 個小珠的陣列可在電域中於數秒内形成。彡重次陣列 (SUbarrayS)的形成也可以在維持在已劃分之晶片表面上的 多重液態相發生。 陣列形成之後,該陣列可為固定化的。舉例而言,小 珠陣列可(舉Μ而言)施加直流電以產生隨機編碼化陣列來 使其固定化。該直流電壓通常設定為5 —η(對2 —6#m範圍 的小珠,且間隙大小在1〇〇-15〇 # m者),且在“反向偏壓 (reverse bias)”結構中供應小於3〇秒的時間,使得n一 doped石夕基貝可形成正極,導致該陣列被壓縮至可在陣列 内促進相鄰小珠之間接觸的程度,且同時導致小珠移向高 電場區域,接近電極表面。一旦在足夠靠近的情形下,小 珠以藉導物理吸附作用的凡德瓦力被固定住。該吸附流程 可藉由在小珠表面提供一群延伸自小珠表面的“拴繫 (tethers)”而被促進;聚離胺酸(p〇lylysine)及 streptavidin已被應用在此目的。 21 200538552 在某些具體實例中,該微粒陣列可經由化學方法來固 定化,例如經由形成一復合的凝膠-微粒薄膜。在一形成 石亥减膠-復合微粒薄膜的示範性的方》中κ共一微微粒 懸浮液,也包含所有用於後續原位置(in-situ)凝膠形成的 所有成77 ,即單體、交鏈劑及起始劑。該微粒係應用 LEAPS方法在裝配在基質上的平面;例如在液態間隙的電 極間提供頻率範圍自100赫兹至數千赫兹的1-20Vp_pAC電 壓。陣列組合之後,在AC電壓存在下,用熱學加熱細胞 〜40-50°C (利用遠紅外線燈或水銀燈源)來誘發液相聚合反 應,使微粒陣列有效的被陷入凝膠内。凝膠可以由丙烯醯 月女(aery 1 amide)及雙丙稀胺(bisacryiamide)各種單體濃度 自20%至5%的混合物所組成(丙烯醯胺:雙丙烯胺=37. 5 : 1 ’莫耳比例),或任何其他低黏性水溶性的單體或單體混 合物亦可以使用。經由該流程所備製的化學固定化功能化 的微微粒陣列可以被用於多種生物分析中,例如配體 (ligand)受體結合分析。 在一貫施例中,熱水凝膠(thermal hydrogel)係利用 在低 /辰度時以 az〇diis〇butyramidine dihyfrochlorise 作 為一熱起始劑而形成,確保該聚合反應混合物的整個離子 強度落在〜(MmM至i.〇mM的範圍内。用於UV聚合反應的 起使劑為 Irgacure 2959® (2-Hydroxy-4,-hydroxythoxy-2-methylpr〇pi〇phenone, ciba Geigy, Tarrytown, NY)。 該起使劑係加入該單體中得到溶液重的丨· 5%。 在某些具體實例中,微粒陣列可以利用機械方法來固 22 200538552 定化。舉例而言,一微孔陣列可以經由標準半導體流程製 方法在矽基質的低阻抗(impedance)區域產生。微粒陣列 可以利用此等結構來形成,例如藉由LEAPS中介流體力學 及pondermotive力,以傳輸及累積微粒在該小洞陣列上。 而後關閉肖AC域’ ^微粒掉人微孔中,因此形成機械性 限制。過置的小珠被移除,留下幾何學條理的隨機小珠陣 列在基質表面上。 基質(例如:晶片)可以被放置在一個或一個以上封閉 的區間内,允許内部聯繫(interc〇nnecti〇n)。反應也可以鲁 在一相似於微滴定量平盤(micr〇titer plate)的開放區間 内進仃。反應試劑可以利用自動液體處理器被微量滴在晶 片的表面,多重檢體可以同時被處理。該種形式對所存在 的微滴定量平盤格式提供標準檢體處理流程及液體處理, 且結合了檢體處理與陣列偵測。 經編碼的小珠也可以被結合在一基質表面(但不在陣列 内)。舉例而言,利用將小珠懸浮液點在基質的多重區域 内,且允許小珠依重力沉澱,小珠組合可以被形成在該基 _ 負上。相對於利用leaps形成小珠陣列,這些組合通常視 為低密度或非平面結構的混亂結構,涉及堆疊或成塊的小 珠因此防止了受影響之小珠的成像。然而,空間與顏色編 碼的組合(利用將化學編碼小珠的混合物點在基質表面的 夕重分離區域)仍舊允許多樣性。 在某些具體實例中,經解碼之陣列影像比較可以被用 於顯示化學或物理區別性的特徵,及探針的延長。舉例而 23 200538552 曰,這樣的比較可以經由且旦/ 及分析儀器的光學顯微鏡;成:二=電腦化影像捕捉 峨示探針延長的光學信號。;取車=析影像係用以 決定該化學性及/或物理性可分㈣取=解碼的影像用以 地鑑認展示於小珠表面的探針 二㈣徵可獨特 的特徵,在陣列上的备— 此種方式’糟由可分辨 。 试粒上的探針身分可以被鑑認, 像分析的演算法可以用在 用在力析取自經解碼(, Such as · Japanese-Japanese film) to form a random weaving I chemical array. Moreover, LEAPS 'can also be used to form a bead array on a light-sensitive electrode ("wafer". Preferably, the above-mentioned sandwich configuration also uses a planar light-sensitive electrode and other planar electrodes. Once again, this February 19 200538552 The poles are separated by a gap and contain an aqueous electrolyte solution. A functionalized and coded bead is introduced into the gap. Using AC voltage and light, the beads form an array on the light-sensitive electrode In some embodiments, the beads can have a chemically optically distinguishable feature. For example, they can be achieved by staining the beads with some optically resolvable labels, such as those containing one or a The above photoluminescence can distinguish fluorescent or chromophore dyes whose excitation wavelength, emission wavelength, excited state lifetime or radiation intensity. The optically distinguishable label can be used to dye beads in a specific ratio, for example , As described in US Patent No. 4, 71 7, 655 (January 5, 1988) by Fulwyler. Dyeing can also be achieved by increasing the particle size using methods familiar to the skilled person, (Molday, Dreyer, Rembaum & Yen, J. Mol Bio 64, 75-88 (1975), L. Bangs, 'uniform iatex particles, Sergen Diagnostics, 1 984). For example, Up to 12 forms of beads are coded using two color swell and bulk stains, each within four intensity gradings and mixed with four nominal mole ratios Alternatively, the method of encoding the combined color (detailed in International Application PCT / US No. 98/1 10719, incorporated by reference) can be used to give the bead array an optically distinguishable label. In addition to chemical encoding, beads can also be made magnetic by the method detailed in International Application No. WO / 01/098765. In addition to the chemical encoding of dyes, beads with certain nucleotide-priming primers can also be used. Separated by space ("spatial encoding"), so that the position of the beads provides some information about the identity of the beads placed in it. 20 200538552 For example, 'Spatial encoding has In the middle of a process System ,, which by using ί}? Αρς * 4 Shang, late night with LEAPS for phase variation of electric field according to the light projected on the substrate in poor grip + t and / or the structure). ^ μ formula to assemble a flat array (any desired impedance at the interface between the LEAPS chip and the liquid creates a lateral gradient 'to ease the force of the electromechanical mechanics of the intermediary array combination. The requirement of t is moderate: in the liquid gap (Usually 10Mm between two planar electrodes) Apply a low AC voltage of typically low ⑥10Vpp. This combination process is fast and optically programmable • gram containing thousands of beads Arrays can be formed in the electrical domain in seconds. The formation of SUbarrayS can also occur in multiple liquid phases maintained on the surface of the divided wafer. After the array is formed, the array can be immobilized. Examples For example, a bead array (for example, M) can be applied with a direct current to generate a random-encoded array to immobilize it. The DC voltage is usually set to 5 —η (for beads in the range of 2 — 6 #m, and the gap is Those with a size of 100-150 # m), and the supply time of less than 30 seconds in the "reverse bias" structure, so that n-doped Shibajibei can form a positive electrode, resulting in the array Compressed to fit The extent to which the contact between adjacent beads is promoted in the column, and at the same time causes the beads to move to the high electric field area, close to the electrode surface. Once in a sufficiently close situation, the beads are used to guide the physical adsorption of van der Waals force. This adsorption process can be facilitated by providing a group of "tethers" on the bead surface that extend from the bead surface; polylysine and streptavidin have been used for this purpose. 21 200538552 In some specific examples, the particle array can be immobilized by chemical methods, for example, by forming a composite gel-particle film. In an exemplary method for forming a shihaimin-composite particle film Kappa is a microparticle suspension, which also contains all components used for subsequent in-situ gel formation, ie monomers, cross-linking agents and initiators. The particles are assembled using the LEAPS method in the assembly A plane on a substrate; for example, a voltage in the range of 100 Hz to several thousand Hz is provided between the electrodes of the liquid gap in the range of 1-20Vp_pAC voltage. After the array is combined, the cells are heated thermally in the presence of AC voltage ~ 40-50 ° C (Using a far-infrared lamp or a mercury lamp source) to induce a liquid phase polymerization reaction, so that the microparticle array is effectively trapped in the gel. The gel can be made of various monomers such as aery 1 amide and bisacryiamide. Mixtures with a body concentration from 20% to 5% (acrylamide: bisacrylamine = 37.5: 1 'mole ratio), or any other low viscosity water-soluble monomer or monomer mixture can also be used The chemically immobilized and functionalized microparticle arrays prepared through this process can be used in a variety of biological assays, such as ligand receptor binding assays. In a consistent embodiment, a thermal hydrogel is formed by using az〇diis〇butyramidine dihyfrochlorise as a thermal initiator at a low temperature, so as to ensure that the entire ionic strength of the polymerization reaction mixture falls within ~ (In the range of MmM to 1.0 mM. The initiator used for the UV polymerization is Irgacure 2959® (2-Hydroxy-4, -hydroxythoxy-2-methylpropiaphenone, ciba Geigy, Tarrytown, NY). The starting agent is added to the monomer to obtain a solution weight of 5%. In some specific examples, the microparticle array can be fixed by mechanical methods. 22 200538552 For example, a microwell array can be calibrated by standard The semiconductor process method is produced in the low-impedance region of the silicon substrate. Particle arrays can be formed using these structures, for example, by using LEAPS to mediate hydrodynamics and pondermotive forces to transport and accumulate particles on the small hole array. Close the Shaw AC domain 'particles fall into the microwells, thus forming a mechanical constraint. The excessive beads are removed, leaving a geometrically-organized random bead array on the surface of the substrate. A matrix (eg, a wafer) can be placed in one or more closed sections to allow internal contact. Interactions can also be performed in a microtiter plate similar to a microtiter plate. The reaction chamber can be opened in the open section. The reaction reagent can be dripped on the surface of the wafer using an automatic liquid processor, and multiple samples can be processed at the same time. This form provides standard sample processing procedures for the existing microtiter plate format and Liquid processing, combining sample processing and array detection. Coded beads can also be combined on the surface of a substrate (but not inside the array). For example, by using bead suspensions in multiple areas of the substrate Inside, and allow beads to sediment by gravity, bead combinations can be formed on the base_negative. Compared to using bead arrays to form bead arrays, these combinations are generally considered as chaotic structures with low density or non-planar structures, involving stacked or Blocked beads thus prevent imaging of the affected beads. However, the combination of space and color coding (using a mixture of chemically coded beads) Even heavy separation areas on the surface of the substrate) still allow for diversity. In some specific examples, decoded array image comparisons can be used to show chemically or physically distinguishing features, and probe extensions. For example, 23 200538552 That is, such a comparison can be made through the optical microscope of the analysis instrument; into: two = computerized image capture of the extended optical signal of the Ashi probe; car picking = analysis image is used to determine the chemical and / or Physically separable = the decoded image is used to identify the unique features of the probes displayed on the surface of the beads, which are prepared on the array-this way is not discernible. The identity of the probe on the test particle can be identified, and the algorithm of image analysis can be used in force analysis.
Ψ m ΛΑ ^ f曰规胛碼的及WΨ m ΛΑ ^ f
乂 、數據。這些演算法可以用;^ / 矣 曰 J ^用於在一陣列内取得每一 數據。該分析軟體會自動利用陣列的明亮-區 〜像作為模㈣出小珠中心根據種類將小珠分群、給 固小珠定量的強度、去除“汙點(blemishes),,(諸如那 在血清檢體中非規則形狀之“基f (matrix),,物質所產 ^ 刀析月厅、強度統計以及對所有小珠型態評估經 正的平均強度和相關的變異性。該演算法的實施例, 在國際申請號第W0 01/098765號中提出。数据, data. These algorithms can be used; ^ / 矣 J ^ is used to obtain each data in an array. The analysis software will automatically use the bright-zone ~ image of the array as a mold to extract the center of the beads, group the beads according to the type, give a fixed amount of strength to the beads, remove "blemishes," (such as in serum samples The "fractal matrix" of the irregular shape in China, the material produced by the knife analysis, the intensity statistics, and the positive average intensity and related variability of all bead types are evaluated. An embodiment of the algorithm, Filed in International Application No. WO 01/098765.
丄。探針的雜交可以由(例如)與探針相結合之小珠的光學 改變而被顯示。此可以利用在該領域中已知的標定方 、-成包含直接及間接標定。在某些具體實例中,螢光 s、化千染劑可以附著在於探針雜交過程中所加入之核苦酸 固使付雜父到其標的的探針改變了小珠的光學信號 d如螢光強度改變,因此使小珠的光學信號改變)。 型性 本文所描述的是針對高度多型性標的區域實施精確多 分析的方法及組合物。多樣性PCR反應的設計、組成 24 200538552 物及方法的相關考量。 在高度多型性位置(1〇ci) 宁夕4+料敗# 夕1性&域挽度致使所選 斤k的多型性區域的探 性區域最接近處的尸…木針(當黏合至選定的多型 y 亞序列時)會與相鄰的多型性區域 且 养核芽酸探針會與其他相鄰的多型性區域社入 ’該探針係設計來在所選的多型性區域之二 : (interrogate)標的的結 合至正確的標的…± /、有足夠的長度來確保當黏 J打的專一性和熱安定性。此 的多型性區域包括非經 二丁儍 經選擇區域。 UK擇位置以及標的序列中非 …本文“述覆蓋性探針組的設計,其係與在多重不相 絰4夂多型性得分中多型性的雜交中介多樣性分析相關 如同對CF攜帶者篩選的突變分析。在此,該用於突變 全:多樣性的覆蓋性組包含多重次組(muHipie _仏 ’母一個次組可結合一經選定的區域。在第二實施例中Alas. Probe hybridization can be shown by, for example, optical changes in the beads bound to the probe. This can be done using calibration methods known in the art, including direct and indirect calibration. In some specific examples, the fluorescent s and dyes can be attached to the nucleoside acid added during the probe hybridization process, which changes the optical signal of the bead to the target probe, such as fluorescent The light intensity changes, thus changing the optical signal of the beads). Types Described herein are methods and compositions for performing accurate multi-analysis on highly polymorphic target areas. Design and Composition of Diversified PCR Reactions 24 200538552 At the position of high polymorphism (1〇ci) Ning Xi 4+ expected to lose # Xi 1 sex & domain retention caused the body closest to the exploratory region of the selected polymorphic region ... wooden needle (when (Adhered to the selected polytype y subsequence) will be adjacent to the polymorphic region and the nucleogenic probe will be incorporated with other adjacent polytype regions.The probe is designed to Polymorphic area two: (interrogate) the combination of the target to the correct target ... ± /, with sufficient length to ensure the specificity and thermal stability of the j when playing. This polymorphic region includes non-dietically-selected regions. The UK selects positions and non-target sequences. This article describes the design of the coverage probe set, which is related to the analysis of polymorphism in the polymorphism in the multiple dissimilarity 4 polymorphism score, as it is for CF carriers. Screened mutation analysis. Here, the coverage group for mutation: diversity includes multiple subgroups (muHipie_ 仏 'maternal subgroup can be combined with a selected region. In the second embodiment
該覆蓋性組包含建構來縮小在組中探針數量的亞組,在, 亦詳盡的描述。 與小珠結合的探針陣列可以用於一群突變的雜交—中介 =析’ fe圍是囊性纖維跨膜傳導調控子(CFTR)基因中非經 这定之犬k及多型性中。在該組中每一經選定的突變係與 該疾病相關,且必須獨立計分。在點突變的例子中,提供 一個編碼化的採針以確定與該選定位置的結合,一探針互 ' 予生型’另一探針則與突變或多型性標的序列結合。 在某些具體實例中,只要覆蓋性探針組所提供的序列 25 200538552 :::::的序列的配對足夠近似,則鐘認非所選區域碰到 特疋糕的構形就不是所關心的了 — 一 以⑽交。在該類的例子中,所有的序列配對 被刀派成相同的密碼,在一較佳具體實例中,該探針 了 =與相同的固體支持物(“探針庫,,)結合。探針庫可降低 可为辨之固態支持物的數量,該支持物 黨齡| & Μ η 罟用來表不所 針。在—特殊較佳的具體實財,所提供的固 心持物係以-組或可分辨的微微例陣列形式出現,其可 :::原位置(in situ)被解碼。在覆蓋性組中所添加額:的 ‘”標的區域内額外的多型性鑑認為說明多樣族 群單一型態(haplotypes)的一有用方法。 適當的探針可以被設計成相應於CFTR基因位置中已知 的對偶基因。一些多型性及突變對偶基因是已知的且可由 文獻及其他來源取得。 溫度控制的標準方法可容易的應用於設定操作(或施用 一系列預先設定的溫度變化至)單一晶片或多重晶片載體 的μ度上。當結合編碼化小珠的全部陣列之直接影像(如 同在多樣性分析中READTM格式所提供的),預先設定的溫 度循環之應用提供了及時晶片上(reabtime 〇n — chip)延長 產物的放大。給予基因組、粒腺體或其他dna,線狀晶片 上放大反應消除了對預分析DNA放大反應(如pcR)的需要 因此大大縮短完成該全部測定試驗的時間。時間敏感性 應用(例如屍首的測定)因此可以實施。更重要的是,該方 法將消除PCR多樣性的複雜性,在許多基因組篩選及多型 26 200538552 性分析中的具有有限的步驟。在一較佳實施例中,一液態 藥筒(cartridge)提供注射檢體及反應試劑,以及溫度控制 Ο 在此所描述之設計、組合物及方法也關於核酸檢體的 多樣性放大反應。在一較佳具體實例中,pcR引子的覆蓋 組(由起始及黏合次序列所組成)係用於標的的放大反應。 在此之後所描述的為一系列針對雜交分析筛選探針及 標的之適當陣列步驟。 作業: ❿ 辨別(選#) -組的探針,p,去同時實施一種或多種 “多樣性(multiplexed),,允許核酸序列雜交中介質疑 (interrogation)的反應,以決定在每一組選定的多型性位 置s= {Sl5 Y,SN;[的組合物,該位置係位於M<或4核酸 股 T : = {T〗,Y,TM}(“標的,,)。 標的一標的的收集T,{Ti = (mi,σί) ; K或=i <或= Μ}係由聚合酶鏈反應(PCR)所產生,其係使用設計來置入多 個多型性或突變到單一標的上的pcR引子,條件是標的長 度li不超過最大長度lmax,且其中i—th標的、長度li的 Ti進一步具有下列特徵: 一多樣性m i, 給予該選定的多型性(或突變)的數目, 其中 Σ (i = l ; i=M)) ;且 一方位值(orientation)σ丨,其中 意義股(“ci s”)的σ , +ι ;或 27 200538552 反義股(“trans”)的 σ ^ -1。 引子-較佳地,突變分析係牵涉每一選定突變位置s 的質疑(interrogation),其係藉由將相應的標的雜交到至k 少二個選定之質疑探針P/及V,其中至少—第_探針” 具有可與正常(“野生型”)組成物互補的序列,且其中至^ 一第二探針P/具有一可與變異(“突變型,,)組成物互補= 序列。在質疑次序列(interrogated subsequence)區域内( 除了在選定的區域)有多型性或突變存在時,理想上通常 會提供“衰退(degenerate),,探針’其會與位於非選定位置鲁 的預期性組成物配對。該較的PA%)此後可理解為指 稱所有針對k-th敎位置的探針,使得pk的特徵為具有 一些探針,這些探針中的每一個具有一方位值^,相反 於該同源的標的。 特別的是,探針係被選擇的,且探針-標的反應係被裝 :己至成牽彡種或一種以上反應組的方式,這些反應中的 每:個係在-分隔的容器内操作,該方法可降低任何包含 、、工k疋的夕型性位置或突變\之標的的次序列與除了# Φ 相對應的選定探針pk反應。 、 隹:、、;不必然產生一最理想配置(conf iguration) 以下的旨试錯誤的化印^討泌广策略提供了試驗最佳化 的^統性流程基礎,包含在二個序列間相似性的一最大可 ,又&度之關鍵*數,其係表示為同源性得分,和一 “交互 亦隹父的取大可接受程度,其係顯示其在“外對角線(〇ff — diag〇nal)凡素的大小(magnitude),-共親合力的PJ/ 28 200538552 見美國申請號第10/2〇 99號, 泌外扮陆以从☆ p名為利用應用-專一隨 多重分析分子分析”)顯示在所給予的族群或 有木針及所有標的之間相互影響的程产 :::小任何所給予的標的及針對其心 :父互雜父,將標的及其相對應的探針分配至…容哭 ’ W乍C個獨立的“多樣性(mul - 該數目可選擇儘可处,从”A )雜乂反應’ ,所…:小的,以使在—相同容器内的標的間 h , 列相似性(“最大同源性得分(maxifflal homology score)”)其預設定最大可接受程度❶ ㈣m小在—㈣容^,在任何所給予的標的及針 量—的的探針間的交互雜交,藉著轉換此㈣十 的方位值及其相對應探針的方位值,允許在新容對2 他任何標的的再選定(reassignment)e 1、 某些標的可具有—v L ΛΛ Γ- ^ 有種以上的區域,母一個標的在陣列 u &疋^針可與之雜交。在此類的案例中,為了縮 小相同的容器内的交互雜交以及競爭雜交,藉由重新設計 引子、、且以降低此類“干擾(of fending),,標的的多樣性, 以產生-個(或以上)較小的標的來置換原始的單—桿的, 每一:新標的比原先的具有較低的雜交區域多樣性。 元成下面的叙編碼(pseudocode)提供一配置 (configuring)該反應的嘗試錯誤流程的敘述,以便降 互雜交。 * 29 200538552 I-分配標的-及同源(cognate)探針-至c組(“容器,,)The coverage group contains subgroups constructed to reduce the number of probes in the group, and is also described in detail. Bead-bound probe arrays can be used for a herd of mutant hybridizations — intermediary = analysis' fe Wai is a non-regulated canine k and polymorphism in the cystic fiber transmembrane conductance regulator (CFTR) gene. Each selected mutation in this group is associated with the disease and must be scored independently. In the case of point mutations, a coded needle is provided to determine binding to the selected position, one probe is 'probiotic' and the other probe is bound to the sequence of the mutation or polymorphism target. In some specific examples, as long as the sequence of the sequence 25 200538552 ::::: provided by the coverage probe set is sufficiently approximated, it is not of concern that the configuration of the non-selected region meets the special cake It's up — one by one. In this type of example, all sequence pairs are assigned the same code by the knife. In a preferred embodiment, the probe is bound to the same solid support ("probe library,"). Probes The library can reduce the number of discriminable solid supports, which are used to make a statement. In-particularly better specific real estate, the provided solid holders are in groups Or in the form of a distinguishable pico instance array, which can be decoded ::: in situ. The additional polymorphism in the area marked by the "" added in the coverage group: It is considered to indicate that the multiple ethnic groups are single. A useful method for haplotypes. Appropriate probes can be designed to correspond to known dual genes in the CFTR gene position. Some polymorphisms and mutant dual genes are known and can be obtained from the literature and other sources. Standard methods of temperature control can be easily applied to set operations (or apply a series of pre-set temperature changes to) μ degrees of a single wafer or multiple wafer carriers. When combined with direct images of the entire array of coded beads (as provided in the READTM format in the diversity analysis), the application of a preset temperature cycle provides a magnification of the reabtime on-chip extended product in time. Given the genome, mitochondria, or other DNA, the amplification reaction on the linear wafer eliminates the need for a pre-analytical DNA amplification reaction (such as pcR) and therefore significantly reduces the time required to complete the entire assay. Time-sensitive applications (such as the determination of cadaver heads) can therefore be implemented. More importantly, this method will eliminate the complexity of PCR diversity, with limited steps in many genomic screening and polymorphism analysis. In a preferred embodiment, a liquid cartridge provides injectable specimens and reaction reagents, and temperature control. The designs, compositions, and methods described herein are also related to amplifying the diversity of nucleic acid specimens. In a preferred embodiment, the overlay set of pcR primers (consisting of the initiation and adhesion sequences) is used for the target amplification reaction. Described below is a series of suitable array steps for screening probes and targets for hybridization analysis. Assignment: ❿ Identify (select #)-group of probes, p, to perform one or more "multiplexed" at the same time, allowing the interrogation reaction in nucleic acid sequence hybridization to determine the selected in each group Polymorphic position s = {Sl5 Y, SN; [composition, this position is located at M < or 4 nucleic acid strand T: = {T〗, Y, TM} ("subject ,,"). A collection of targets T, {Ti = (mi, σί); K or = i < or = Μ} is produced by polymerase chain reaction (PCR), which uses design to place multiple polytypes Or mutated to a single pcR primer, provided that the target length li does not exceed the maximum length lmax, and the i-th target Ti with length li further has the following characteristics: a diversity mi, which gives the selected polymorphism (Or mutations), where Σ (i = l; i = M)); and an orientation value σ 丨, where σ of the meaning unit ("ci s"), + ι; or 27 200538552 antisense Sigma ("trans") of σ ^ -1. Primers-Preferably, the mutation analysis involves the interrogation of each selected mutation position s by hybridizing the corresponding target to at least two selected challenge probes P / and V, where at least- The _probe ”has a sequence that can be complementary to a normal (" wild type ") composition, and wherein up to a second probe P / has a sequence that can be complementary to a variant (" mutant, ") composition. When interrogated subsequence regions (except in selected regions) are polymorphic or mutated, ideally a "degenerate" is provided, and the probes are Expected composition pairing. The comparative PA%) can be understood as referring to all probes targeting the k-th 敎 position, so that pk is characterized by having some probes, each of which has an orientation value ^ , In contrast to the target of the same origin. In particular, the probe system is selected, and the probe-target reaction system is loaded: in a manner that can be a strain or one or more reaction groups, each of these reactions: Each system is operated in a -separated container. This method can reduce the reaction of any subtypes that contain, or the position of the mutation or the target of the mutation \ with the selected probe pk corresponding to except Φ. 隹: 、,; does not necessarily produce an optimal configuration (conf iguration) The following test and error analysis method is provided. The strategy provides a basis for systematic optimization of experimental optimization. It includes one of the similarities between the two sequences. Max, again & The key * number, which is expressed as the homology score, and an "interaction is also the maximum acceptable degree of the father, which shows its size in the" outer diagonal (〇ff — diag〇nal) (Magnitude),-Co-affinity PJ / 28 200538552 See U.S. Application No. 10 / 2〇99, Bi Wai Shi Lu uses the name ☆ p for application-specific molecular analysis with multiplex analysis ") shown in the given Ethnic group or the process that has a mutual influence between wooden needles and all targets ::: Any target given and targeted at its heart: Fathers and fathers, assign targets and their corresponding probes to ... There are independent "multipliers (mul-the number can be chosen as much as possible from the" A "hybrid reaction), so ...: small, so that the similarity between the targets in the same container, the column similarity ("Maxifflal homology score") its preset maximum acceptable level ❶ 小 m is small-㈣ capacity ^, cross-hybridize between any given target and needle amount- By shifting the bearing value of this unit and its corresponding probe, allow any other Target reassignment e 1. Some targets may have -v L ΛΛ Γ- ^ There are more than one kind of region, and a target in the array u & 疋 ^ needles can hybridize with it. In such cases, in order to reduce the cross hybridization and competitive hybridization in the same container, by redesigning the primers and reducing such "of fending," the diversity of the target to generate a ( (Or above) smaller targets to replace the original single-rod, each: the new target has a lower diversity of hybridization regions than the original. The following pseudocode of Yuancheng provides a configuration for the reaction The description of the process of trial and error in order to reduce cross-hybridization. * 29 200538552 I-assignment target-and cognate probe-to group c ("container,")
c= 0 ; DO REFSEQ=選擇標的⑺ 縮減選擇(Γ,1) S= L(c); 起草目錄(L(g),REFSEQ); 自所提供的集合中隨機選擇一標的 序列,T*/ /*自集合中移除經選擇的標的*/ /將經選擇的標的放至新組(“族群,,)中 … ’在一目錄格式中執行,S*/ 排列標的(REFSEQ,r,HScores);/*排列剩餘的標的至REFSEq ,利用 配對排列或多重序列排列對;回歸同 、, 源性得分*/c = 0; DO REFSEQ = selection target 选择 Reduced selection (Γ, 1) S = L (c); Draft directory (L (g), REFSEQ); Randomly select a target sequence from the provided set, T * / / * Remove selected targets from the set * / / Place the selected targets in a new group ("Clan ,, ..." ... 'Execute in a directory format, S * / arrange the targets (REFSEQ, r, HScores ); / * Arrange the remaining targets to REFSEq, use paired permutations or multiple sequence permutation pairs; regression homology, source score * /
分類標的(Hscores,7) /*根據同源性得分相關REFSEQ的 增加排列標的序列;首先放入最不相 似的,最後放入與REFSEQ最為相 似者*/ ^一 ^配標的(maxHsC0RE,/*自集合中根據增加的同源性得分( ,,); 至maxHSC〇re)移除標的,並將它們 置入表中,從上開始;回歸排列在該 目錄中的標的數目,S * / t) /*自集合中移除t經選擇的標的*/ }當(/不為空白);Classification target (Hscores, 7) / * Arrange the target sequence according to the increase in REFSEQ related to the homology score; first put the least similar, and finally put the most similar to REFSEQ * / ^ 一 ^ (HHCCRERE, / * Remove the targets from the set according to the increased homology score (,,); to maxHSC〇re), and put them into the table, starting from the top; return the number of targets arranged in the directory, S * / t ) / * Remove the selected subject * /} from the set when (/ is not blank);
視需要地,一種或一種以上的目錄可被刪除,若其包含多 於一可接受數目的標的時(舉例而言,假設其被:定基於 在一目錄中有過多的標的,maxHscore應被降低),根據自 該目錄的-種或-種以上的下端移除標的,且放置該標的 至集合7中。 I卜提升族群配置 當(i=0; I<c; i++) 依序測試每個族群*/ 的㈣出針尉目前目錄‘ { S-L(i);If necessary, one or more directories can be deleted, if it contains more than an acceptable number of targets (for example, assuming it is: based on having too many targets in a directory, maxHscore should be reduced ), Remove the target from the lower end of the category or more than the category, and place the target in the collection 7. I. Improving the ethnic group configuration When (i = 0; I <c; i ++) sequentially test the current directory of each ethnic group * / ‘{S-L (i);
Po仏選擇探針〇P,S) 30 200538552 當(S不為空白) T- PopTarget (S); 進行探針標的反應(P〇fS,T) 當(每一探針P,在PofS中) /*每一探針係被設計與至少一個標的 相配對,這係指該探針與該標的為 同源;注意:參照在共親合力陣列中 的對角線(diagonal)元素*/ /*使T與所有經選擇的探針接觸,較 佳的是排列在探針陣列内*/ 1=決定交互作用強度(P,T); /*縮小在共親合力陣列中 大外對角線元素*/ 若((P不與T同源)及(I> maxi) /*翻轉探針的方位值*/ 翻轉方位(P); 翻轉方位(TcP); /*翻轉與P同源的標的方位值*/ 翻^的PopTarget⑻;/*確認在目錄s中的“翻轉,,標的*/ T)進行探針標的反應(p〇fS,翻轉的/*使τ與所有經選擇的探針 佳的是在探針陣列中*/ 較 每一個探針P,在PofS中) k決定交互作用強度(P,經翻轉的T); /*縮小在共親合力陣列中不可接 若大外對角線元素*/ 安又的 up與經翻轉的τ不同源)以及(I> maxI) 目錄 */ 推動標的(經翻轉的τ,TempList); /*放置翻轉標的至臨時 31 200538552 S=TempList; 當(S不為空白){ T= PopTarget (S); 當(j=0;j<c;j++){ 正①⑼吐⑺){ 目錄S臨時保留經翻轉的標的~ /*確魂在臨時目錄内的標的*/ T) (T)); (PcT); 目錄); 認T對抗在所有存在的目錄 除了那些在T,s的原始目錄中*/ τ一、 l=lg); 目錄(L)中選擇探針;/*在族群l中選擇探針” 進仃楝針標的反應_L,/*將T與所有經選擇的探^接觸, f (每-個探針P,在隱巾^是排列在探針陣列内~ 1==決定交互作用強度(P,T); /縮小在共親合力陣列中不可接受 大外對角線元素*/ 若((P與T不同源)以及(I> maxI)) 翻轉方位/**/翻轉標的方位值使回覆成原始狀態 翻轉方位/*翻轉探針的方位值 與標的T同源*/ 推動標的(T,新/*開始新族群*/Po 仏 Select probes (P, S) 30 200538552 When (S is not blank) T- PopTarget (S); Perform the probe target reaction (Pfs, T) When (each probe P, in PofS) / * Each probe is designed to be paired with at least one target, which means that the probe is homologous to the target; note: refer to the diagonal elements in the co-affinity array * / / * Contact T with all selected probes, preferably arranged in the probe array * / 1 = determines the strength of the interaction (P, T); / * Reduce the large outer diagonal elements in the co-affinity array * / If ((P is not homologous to T) and (I > maxi) / * orientation value of flip probe * / flip orientation (P); flip orientation (TcP); / * flip the orientation of the target homologous to P The value of * / turned PopTarget⑻; / * confirm that the "turned, * * T" in the directory s performs the probe-targeted reaction (p0fS, turned / * makes τ better than all selected probes) Is in the probe array * / compared to each probe P, in PofS) k determines the strength of the interaction (P, flipped T); / * narrows down in the co-affinity array which cannot be as large as the outer diagonal Element * / An up and upside down (Different sources) and (I &max;) directory * / push target (inverted τ, TempList); / * place flip target to temporary 31 200538552 S = TempList; when (S is not blank) {T = PopTarget (S) When (j = 0; j <c; j ++) {正 ①⑼ 吐 ⑼) {The directory S temporarily retains the inverted target ~ / * the target of the soul in the temporary directory * / T) (T)); (PcT ); Directory); Recognize T confrontation in all existing directories except those in the original directory of T, s * / τ a, l = lg); select probes in directory (L); / * select probes in group l Needle ”into the needle's response_L, / * contact T with all selected probes, f (each-probe P, the hidden towel ^ is arranged in the probe array ~ 1 == decides the interaction Intensity of action (P, T); / Reduction of large outer diagonal elements is not acceptable in co-affinity arrays * / If ((P and T are different sources) and (I > maxI)) flip orientation / ** / flip target The bearing value makes the response return to the original state. Flip bearing / * The bearing value of the flip probe is the same as the target T * / Push the target (T, new / * start new ethnic group * /
翻轉方位(P); /*翻轉探針方位*/ 翻轉方位(TcP); /*翻轉與P同源的標的方位值*/ 32 200538552 【實施方式】 實施例I : CFTR試驗 自數個病人中萃取出的基因組DNA以相對應的引子在 一多重PCR(mPCR)反應中放大之。該PCR條件及反應試劑 如下: 引子設計:該引子的其中一個(意義股或反義股,依設 計考量,於後討論)係以一標籤(例如Cy3、Cy5及Cy5· 5) 在5’端進行修飾,且用以互補序列的相對應引子具有一加 在5’端的磷酸基團,使擴增子可以在標的的後PCR流程中 被又内切酶切割(見之後敘述)。利用偵測在雜交產物中的 染劑(Cy3、Cy5或Cy5. 5)來偵測雜交。多重PCR(mPCR)係 以二個族群以下列引子(表I及表11)實施,且使用下列反 應試劑及條件。突變所在位置的外顯子數目表示在表I及 表11的左側欄中。Inverted orientation (P); / * Inverted probe orientation * / Inverted orientation (TcP); / * Inverted orientation value with the same origin as P * / 32 200538552 [Embodiment] Example I: CFTR test from several patients The extracted genomic DNA is amplified by corresponding primers in a multiplex PCR (mPCR) reaction. The PCR conditions and reaction reagents are as follows: Primer design: one of the primers (meaning or antisense, depending on design considerations, discussed later) is labeled with a label (such as Cy3, Cy5, and Cy5 · 5) at the 5 'end Modifications and corresponding primers for complementary sequences have a phosphate group added to the 5 'end, so that the amplicon can be cleaved by the endonuclease in the target post-PCR process (see below). Hybridization was detected using a dye (Cy3, Cy5 or Cy5. 5) detected in the hybridization product. Multiplex PCR (mPCR) was performed in two groups with the following primers (Table I and Table 11), and the following reaction reagents and conditions were used. The number of exons at the position of the mutation is shown in the left column of Table I and Table 11.
表ITable I
人工序列人工引子 mPCR族群I引子:(“Cy”表示染劑標籤,且’’P”表示在引子 5’端的磷酸修飾) SEQ ID NO.:l SEQ ID NO.:2 SEQ ID NO.:3 SEQ ID NO.:4 SEQ ID NO.:5 SEQ ID NO.:6 SEQ ID NO.:7 SEQ ID NO.:8 SEQ ID NO.:9 SEQ ID NO.:10 SEQ ID NO·: 11Artificial Sequence Artificial Primer mPCR Group I Primer: ("Cy" represents the dye tag, and "P" represents the phosphate modification at the 5 'end of the primer) SEQ ID NO.:l SEQ ID NO.:2 SEQ ID NO.:3 SEQ ID NO .: 4 SEQ ID NO .: 5 SEQ ID NO .: 6 SEQ ID NO .: 7 SEQ ID NO .: 8 SEQ ID NO .: 9 SEQ ID NO .: 10 SEQ ID NO: 11
EX-5-l-Cy GTC AAG CCG TGT TCT A GAT EX-5-2-P GTT GTA TAA TTT ATA ACA ATA GTEX-5-l-Cy GTC AAG CCG TGT TCT A GAT EX-5-2-P GTT GTA TAA TTT ATA ACA ATA GT
EX-7-1 -P AC TTC AAT AGC TCA GCC TTC EX-7-2-Cy TAT GGT ACA TTA CCT GTA TTT TG EX-9-1 -P TGG TGA CAG CCT CTT CTT EX-9-2-Cy GAA CTA CCT TGC CTG CTC CA EX-12-1-P TCT CCT TTT GGA TAC CTA GAT EX-12-2-Cy TGA GCA TTA TAA GTA AGG TATEX-7-1 -P AC TTC AAT AGC TCA GCC TTC EX-7-2-Cy TAT GGT ACA TTA CCT GTA TTT TG EX-9-1 -P TGG TGA CAG CCT CTT CTT EX-9-2-Cy GAA CTA CCT TGC CTG CTC CA EX-12-1-P TCT CCT TTT GGA TAC CTA GAT EX-12-2-Cy TGA GCA TTA TAA GTA AGG TAT
EX-13-1-P AGG TAG CAG CTA TTT TTA TGG EX-13-2-Cy ATC TGG TAC TAA GGA CAGEX-13-1-P AGG TAG CAG CTA TTT TTA TGG EX-13-2-Cy ATC TGG TAC TAA GGA CAG
EX-14B-1-P TCT TTG GTT GTG CTG TGG CT 33 200538552EX-14B-1-P TCT TTG GTT GTG CTG TGG CT 33 200538552
EX-14B-2-Cy EX16A-1P EX16A-2-Cy EX-18-1-P EX18-2-Cy Ex-19-l-Cy Ex-19-2-PEX-14B-2-Cy EX16A-1P EX16A-2-Cy EX-18-1-P EX18-2-Cy Ex-19-l-Cy Ex-19-2-P
ACA ATA CAT ACA AAC ATA GT CTT CTG CTT ACC ΑΤΑ TTT GAC TAAT ACA GAC ATA CTT AAC G GG AGA AGG AGA AGG AAG AGT ATC TAT GAG AAG GAA AGA AGA GGC CAA ATG ACT GTC AAA GA TGC TTC AGG CTA CTG GGA TT SEQ ID NO.: 12 SEQ ID NO.: 13 SEQ ID NO·: 14 SEQ ID NO.: 15 SEQ ID NO·: 16 SEQ ID NO.:17 SEQ ID NO·: 18ACA ATA CAT ACA AAC ATA GT CTT CTG CTT ACC ΑΤΑ TTT GAC TAAT ACA GAC ATA CTT AAC G GG AGA AGG AGA AGG AAG AGT ATC TAT GAG AAG GAA AGA AGA GGC CAA ATG ACT GTC AAA GA TGC TTC AGG CTA CTG GGA TT ID NO .: 12 SEQ ID NO .: 13 SEQ ID NO .: 14 SEQ ID NO .: 15 SEQ ID NO .: 16 SEQ ID NO .: 17 SEQ ID NO .: 18
表II mPCR族群II引子:Table II mPCR Group II primers:
Ex-3-l-Cy Ex-3-2-P Ex-4-l-P Ex-4-2-Cy EX-10-1-P EX-lO-2-Cy Ex-ll-l-P EXll-2-Cy Int-19-l-Cy Int-19-2-P EX-20-1-P EX20-2-Cy EX21-1-P EX21-2-CyEx-3-l-Cy Ex-3-2-P Ex-4-lP Ex-4-2-Cy EX-10-1-P EX-lO-2-Cy Ex-ll-lP EXll-2-Cy Int-19-l-Cy Int-19-2-P EX-20-1-P EX20-2-Cy EX21-1-P EX21-2-Cy
C GGC GAT GTT TTT TCT GGA G T ACA AAT GAG ATC CTT ACC C AGC TTC CTA TGA CCC GGA TA TGT GAT GAA GGC CAA AAA TG TGT TCT CAG TTT TCC TGG AT CTC TTC TAG TTG GCA TGC TT CAG ATT GAG CAT ACT AAA AG AC ATG AAT GAC ATT TAC AGC AA TCA TTC AGT GGG TAT AAG C CCT CCT CCC TGA GAA TGT TGG C TGG ATC AGG GAA GA GAA GG TCC TTT TGC TCA CCT GTG GT TGA TGG TAA GTA CAT GGG TG CAA AAG TAC CTG TTG CTC CA SEQ ID NO.:19 SEQ ID NO.:20 SEQ ID NO.:21 SEQ ID NO.:22 SEQ ID NO.:23 SEQ ID NO.:24 SEQ ID NO.:25 SEQ ID NO.:26 SEQ ID NO.:27 SEQ ID NO.:28 SEQ ID NO.:29 SEQ ID NO.:30 SEQ ID NO.:31 SEQ ID NO.:32C GGC GAT GTT TTT TCT GGA GT ACA AAT GAG ATC CTT ACC C AGC TTC CTA TGA CCC GGA TA TGT GAT GAA GGC CAA AAA TG TGT TCT CAG TTT TCC TGG AT CTC TTC TAG TTG GCA TGC TT CAG ATT GAG CAT ACT AAA AG AC ATG AAT GAC ATT TAC AGC AA TCA TTC AGT GGG TAT AAG C CCT CCT CCC TGA GAA TGT TGG C TGG ATC AGG GAA GAA GG TCC TTT TGC TCA CCT GTG GT TGA TGG TAA GTA CAT GGG TG CAA AAG TAC CTG TTG CTC CA SEQ ID NO.:19 SEQ ID NO.:20 SEQ ID NO.:21 SEQ ID NO.:22 SEQ ID NO.:23 SEQ ID NO.:24 SEQ ID NO.:25 SEQ ID NO.:26 SEQ ID NO.:27 SEQ ID NO.:28 SEQ ID NO.:29 SEQ ID NO.:30 SEQ ID NO.:31 SEQ ID NO.:32
PCR主要混合組成物Main composition of PCR
為20// 1反應/樣本: 成分 體積(//D 10XPCR緩衝液 2.0 25mM MgCl2 1.4 dNTPs (2.5mM) 4.0 引子混合物(多重l〇x) 3.0 7¾分DNA聚合酶 0.6 ddH20 3.0 DNA 6.0 總體積 20 34 200538552 PCR循環條件 供熱開始 94〇C 15分 94〇C 30 秒,60% ramp 60°C 30 秒,50% ramp 72〇C 50 秒,35% ramp 72〇C 8分 利用一 Perkin Elmer 9700 30循環 針對每一引子對,決定其最適引子濃度。反應體積可以根 據實驗所需而調整。 _ 磋户浚裡··在放大反應之後,PCR產物係利用一 QIAqiuck PCR 純化套組(QIAGEN,Cat #281 04)或以核酸外 切酶I處理(Amersham)加以純化。對後者程序而言:將8 # 1流份(a 1 i quot)的PCR產物加到一乾淨且含有2 5 // 1 核酸外切酶I(Amersham)的試管内,在3TC培養15分鐘, 而後將其在80它變性15分鐘。此後,單股的DNA可經由 下列方式產生: PCR反應產物係與2. 5單位的久核酸外切酶在i倍緩 衝液中進行37 C培養20分鐘,接著利用加熱至75。匸1〇 =鐘將酵素去活化。s這些條件了,該酵素自該磷酸化 端分解雙股DNA中的一股,且釋放出5_磷酸化單核苷酸 t Little等人,1967)。單股標的也可以經由其他在 。玄領域中已知的方法產生,然而對該pcR i物加熱用以產 生單股DNA是不理想的。該單股醒可以在陣列中直接被 35 200538552 利用。 遠方 交-自 Genebank&ww’ncJiijxij^^j^iji^g^)所 得的CFTP基因序列係用作野生型模式。將52個探針根據 其序列的同源性分成兩組,係依照“嘗試錯誤(heuristic),, 採針選擇規則系統(alg〇rithm),即在該種方法中避免在可 能範圍中不同探針的重疊同源性。包含在每一族群中的突 變係經選擇的,以便縮小在任何族群中的探針序列之間的 重豐性,且因此用以縮小在多重分析條件下内—族群 (intra-group)的交互雜交。 探針序列係經由PRIMER 3.0軟體設計(見 在此係作為附錄),使每一 個探針具有下列特徵·· (b) —錯誤配對位於該探針的中央部位; (c) 探針長度為i6 —21鹼基; (d )低自我互補性,· (e)含30-60% GC含量;及 (f )不超過三個連續的相同鹼基。 每一個探針序列係與其互補的外 顯子序列排列。見20 // 1 reaction / sample: composition volume (// D 10XPCR buffer 2.0 25mM MgCl2 1.4 dNTPs (2.5mM) 4.0 primer mix (multiple 10x) 3.0 7¾ points DNA polymerase 0.6 ddH20 3.0 DNA 6.0 total volume 20 34 200538552 PCR cycle conditions Heating start 94 ° C 15 minutes 94 ° C 30 seconds, 60% ramp 60 ° C 30 seconds, 50% ramp 72 ° C 50 seconds, 35% ramp 72 ° C 8 minutes Use a Perkin Elmer 9700 30 cycles for each primer pair to determine the optimal primer concentration. The reaction volume can be adjusted according to the needs of the experiment. _ 户户 浚 里 · After the amplification reaction, the PCR product is a QIAqiuck PCR purification kit (QIAGEN, Cat # 281 04) or purified with exonuclease I treatment (Amersham). For the latter procedure: add 8 # 1 fraction (a 1 i quot) of PCR products to a clean and containing 2 5 // 1 In a test tube of exonuclease I (Amersham), incubate at 3TC for 15 minutes, and then denature it at 80 for 15 minutes. After that, single-stranded DNA can be produced by: PCR reaction product and 2.5 units of Exonuclease in 37 C culture in i-fold buffer 20 Minutes, followed by heating to 75. 匸 10 = bell to deactivate the enzyme. Under these conditions, the enzyme breaks down one strand of double-stranded DNA from the phosphorylated end and releases a 5-phosphorylated single nucleotide. t Little et al., 1967). Single-share targets can also be obtained through others. It is produced by a method known in the field of metaphysics, however, it is not desirable to heat the pcR material to generate single-stranded DNA. This single strand wake can be used directly in the array by 35 200538552. Distant cross-CFTP gene sequence obtained from Genebank & ww'ncJiijxij ^^ j ^ iji ^ g ^) was used as a wild-type pattern. The 52 probes were divided into two groups based on their sequence homology. They were based on "heuristic" and "algorithm". That is, in this method, different probes in the possible range are avoided. Overlapping homology of the needles. Mutants contained in each population were selected to reduce the heavy abundance between probe sequences in any population, and were therefore used to narrow the population within multiple analysis conditions-populations (intra-group) cross-hybridization. The probe sequence is designed by PRIMER 3.0 software (see this series as an appendix), so that each probe has the following characteristics ... (b) — the mismatch is located in the center of the probe (C) probe length is 6-21 bases; (d) low self-complementarity, (e) contains 30-60% GC content; and (f) no more than three consecutive identical bases. Each The probe sequence is aligned with its complementary exon sequence. See
lllt.p;//searrhlai]p.hprihrTri / ,在此系列為附錄。計算每一模 母彳木針及非所欲標的序列丨 ’除了該探針欲雜交的突變庠 列外的其他突變序列)間 冋源性的比例,且選擇探針 便在相同陣列内的每個突 的铋針及非所欲標的序列間 N,原丨生比例少於50%。 36 200538552 *針的選擇係根據該f試錯誤選擇規則“進— :八如上,。探針選擇也可因實驗選擇而部分被改善,且 4刀的考s在於包含錯誤配對的驗基對(特別I G 向於穩定者。在探針可*正確地與錯誤輯雜 ”;、 u對的料巾,且在某些其㈣子中,㈣穩Λ—2 配對可以被避免,或如果實驗證明該不正確的雜交可藉由 使用反義股探針被降低時,則係使用反_意義股探針^ 不用意義股探針。使用反義股探針的案例在以 列表IU中指出。 十序 合成26個CF突變的野生型與突變型探針,在其5,端 進行5’生物素-TEG或胺基修飾(合併〇叫咖鑛a技術 )。不同小珠化學可以使用一不同的5,端,使生物素修飾 可結合至塗覆有neutravidin的小珠,且胺基修飾可以結 合至包覆有BSA的小珠。探針係被溶解於1χ 了£或去離子 水中,濃度為100//M。對每一種型態的小珠而言,含有1% 小珠固體的100# 1液態溶液係經5〇〇// i的TBS — Klx te, 〇.5MNaC12)沖洗三次。探針被加到5〇〇/Μ的小珠懸浮液 中,且在室溫下在滾筒(roller)中培養45一6〇分鐘。小珠 以 TBS-T 溶液(Π ΤΕ,0·15Μ NaCl2,·05% Tween 2〇)或 PBS-T(磷酸緩衝鹽,Tween 20)清洗一次,及以TBS_2(1X TE,0· 15M NaC 12)清洗一次,及重新懸浮在ΐχ TBS-2溶液 中。小珠如前述結合在晶片表面上。也將探針分成兩組並 組裝在兩個分開的晶片上。將一第三族群結合進行反射試 驗(包括5Τ/7Τ/9Τ多型性)。負與正控制組也被包含在該晶 37 200538552 片表面,分析信號係使用這些控制組校正之。對負控制組 而言,小珠係與dCTP(01 igo-C)的1 0-mer股結合,且固定 在晶片表面上。對正控制組而言,係使用人類/3肌動蛋白 序列。產生自01 igo-C的信號係作為背景值用以扣除干擾 ,而/3肌動蛋白係用來標準化數值。 表IIIA -雜交族群I 小珠群 突變 小珠群 突變 1 OLIGO-C (控制組) 19 G542-M 2 BA 20 G551D-WT 3 OligoC-1 21 G551D-M 4 G85E-WT 22 R560-WT 5 G85E-M 23 R560-M 6 621+1G>T-WT 24 R553X-WT 7 621+1G>T-M 25 R553X-M 8 R117H-WT 26 OLIGOC-3 9 R117H-M 27 1717-1G>A-WT 10 I148-WT 28 1717-1G>A-M 11 I148-M 29 3849+10kb-WT 12 A455E-WT 30 3849+10kb-M 13 A455E-M 31 W1282X-WT 14 508-WT 32 OLIGOC-4 15 OLIGOC-2 33 W1282X-M 16 F508 34 N1303K-WT 17 1507 35 N1303K-M 18 G542-WT 36 0LIG0C-5lllt.p; //searrhlai]p.hprihrTri /, this series is an appendix. Calculate the ratio of virulence between each mold parental needle and non-desired target sequences (except for the mutation sequence in which the probe is to hybridize), and select each probe in the same array. The protozoan ratio of N between the protruding bismuth needle and the undesired target sequence is less than 50%. 36 200538552 * The selection of the needle is based on the error selection rules of the f test "into: eight as above. The probe selection can also be partially improved due to the experimental selection, and the test of the 4-knife consists of the test base pair containing the wrong pairing ( In particular, IG is stable. The probe can be correctly mixed with the error "; u pair of towels, and in some of its mules, the stable Λ-2 pairing can be avoided, or if the experiment proves When the incorrect hybridization can be reduced by using the antisense strand probe, the anti_sense strand probe is used ^ The sense strand probe is not used. The case of using the antisense strand probe is indicated in the list IU. Twenty-six CF-mutated wild-type and mutant probes were synthesized in sequence, and 5 'biotin-TEG or amine modification was performed at the 5' end (combined with the technology called Kamine a). Different bead chemistry can use a different At the 5, end, the biotin modification can be bound to the beads coated with neutravidin, and the amine modification can be bound to the beads coated with BSA. The probe system is dissolved in 1χ or deionized water at a concentration of 100 // M. For each type of bead, 100 # 1 containing 1% bead solids State solution system was 5〇〇 // i of TBS - Klx te, 〇.5MNaC12) washed three times. The probe was added to a 500 / M bead suspension and incubated in a roller at room temperature for 45-60 minutes. The beads were washed once with TBS-T solution (ΠTE, 0.15M NaCl2, · 05% Tween 20) or PBS-T (phosphate buffered saline, Tween 20), and TBS_2 (1X TE, 0.15M NaC 12 ) Wash once and resuspend in ΐχ TBS-2 solution. The beads are bonded to the wafer surface as previously described. The probes were also divided into two groups and assembled on two separate wafers. Combine a third group to perform a reflection test (including 5T / 7T / 9T polymorphism). Negative and positive control groups are also included on the surface of this crystal. The analysis signal is corrected using these control groups. For the negative control group, the beads were combined with 10-mer strands of dCTP (01 igo-C) and fixed on the wafer surface. For the positive control group, human / 3 actin sequences were used. The signal generated from 01 igo-C was used as the background value to subtract interference, and the / 3 actin system was used to normalize the value. Table IIIA-Hybrid population I Bead population mutation Bead population mutation 1 OLIGO-C (control group) 19 G542-M 2 BA 20 G551D-WT 3 OligoC-1 21 G551D-M 4 G85E-WT 22 R560-WT 5 G85E -M 23 R560-M 6 621 + 1G > T-WT 24 R553X-WT 7 621 + 1G > TM 25 R553X-M 8 R117H-WT 26 OLIGOC-3 9 R117H-M 27 1717-1G > A-WT 10 I148 -WT 28 1717-1G > AM 11 I148-M 29 3849 + 10kb-WT 12 A455E-WT 30 3849 + 10kb-M 13 A455E-M 31 W1282X-WT 14 508-WT 32 OLIGOC-4 15 OLIGOC-2 33 W1282X -M 16 F508 34 N1303K-WT 17 1507 35 N1303K-M 18 G542-WT 36 0LIG0C-5
38 20053855238 200538552
表IIIB-雜交族群IITable IIIB-Hybrid Group II
小珠群 突變 小珠群 突變 1 BA 18 3659delC-WT 2 1898+5G-WT 19 3659delC-M 3 OLIGO-C (控制組) 20 OLIGO-C-3 4 1898+5G-M 21 R1162X-WT 5 OLIGO-C-1 22 R1162X-M 6 R334W-WT 23 2789+5G-WT 7 R334W-M 24 2789+5G-M 8 1898+1G〉A-WT 25 3120+1G>A-WT 9 1898+1G>A - WT 26 3120+1G>A-WT 10 1078delT-M 27 OLIGO-C-4 11 OLIGO-C-2 28 A455E-WT 12 D1152-WT 29 A455E-M 13 D1152-M 30 2184delA-WT 14 R347P-WT 31 2184delA-M 15 R347P-M 32 1078delT-WT 16 17 711+1G>T-WT 711+1G>T-M 33 OLIGO-C-5 表三me-雜交族群in Cluster # (共6族群) 突變 1 石肌動蛋白 1 Oligo C 2 5T 3 7Τ 4 9Τ 用以偵測每一個突變的探針序列係如下列(如前述針對意 義股或反義股序列選擇探針):Bead group mutation 1 BA 18 3659delC-WT 2 1898 + 5G-WT 19 3659delC-M 3 OLIGO-C (control group) 20 OLIGO-C-3 4 1898 + 5G-M 21 R1162X-WT 5 OLIGO -C-1 22 R1162X-M 6 R334W-WT 23 2789 + 5G-WT 7 R334W-M 24 2789 + 5G-M 8 1898 + 1G> A-WT 25 3120 + 1G > A-WT 9 1898 + 1G > A -WT 26 3120 + 1G> A-WT 10 1078delT-M 27 OLIGO-C-4 11 OLIGO-C-2 28 A455E-WT 12 D1152-WT 29 A455E-M 13 D1152-M 30 2184delA-WT 14 R347P-WT 31 2184delA-M 15 R347P-M 32 1078delT-WT 16 17 711 + 1G> T-WT 711 + 1G> TM 33 OLIGO-C-5 Table 3 me-hybrid groups in Cluster # (total 6 groups) Mutation 1 Stone muscle Kinesin 1 Oligo C 2 5T 3 7T 4 9T The probe sequences used to detect each mutation are as follows (such as the aforementioned probe selection for sense strand or antisense strand sequence):
表IV 正常/變異性 序列 捕捉探針 SEQ ID NO.:33 SEQ ID NO.:34 SEQ ID NO.:35 SEQ ID NO.:36 EX-3 AT GTT CTA TGG AAT CTT ΤΤ ΤΑ G85E AT GTT CTA TGA AAT CTT ΤΤ ΤΑTable IV Normal / variant sequence capture probes SEQ ID NO.:33 SEQ ID NO.:34 SEQ ID NO.:35 SEQ ID NO.:36 EX-3 AT GTT CTA TGG AAT CTT ΤΤ ΤΑ ΤΑΑ85E AT GTT CTA TGA AAT CTT ΤΤ ΤΑ
EX-4 ΤΑ TAA GAA GGT AAT ACT TC CTEX-4 ΤΑ TAA GAA GGT AAT ACT TC CT
621-M TA TAA GAA GTT AAT ACT TC CT 39 200538552621-M TA TAA GAA GTT AAT ACT TC CT 39 200538552
CC TCA TCA CAT TGG AAT GC AG CC TCA TCA CAC TGG AAT GC AG CAA GGA GGA ACG CTC TAT CG C CAA GGA GGA ACA CTC TAT CG C ATG GGT ACA TAC TTC ATC AA A ATG GGT ACA TAA TTC ATC AA A GAA TAT TTT CCG GAG GAT GAT GAA TAT TTT CCA GAG GAT GAT CAT TGT TCT GCG CAT GGC GGT CAT TGT TCT GCC CAT GGC GGT CT CAG GGT TCT TTG TGG TG TT CT CAG GGT TC TTG TGG TG TT ACA GTT GTT GGC GGT TGC TGG ACA GTT GTT GGA GGT TGC TGG AAA GAA AAT ATC ATC TTT GGT AAA GAA AAT ATC ATT GGT GT AAA GAA AAT ATC TTT GGT GT ATA TTT GAA AGG TAT GTT CT TT ATA TTT GAA AGA TAT GTT CT TT GAA ACA AAA AAA CAA TCT TTT GAA ACA AAA AA CAA TCT TTT TTG GAA AGT GAG TAT TCC ATG TTG GAA AGT GAA TAT TCC ATG ACT TCA TCC AGA TAT GTA AAA ACT TCA TCC AGG TAT GTA AAA TAT AGT TCT TGG AGA AGG TGG TAT AGT TCT TTG AGA AGG TGG TCT TTA GCA AGG TGA ATA ACT TCT TTA GCA ACG TGA ATA ACT GAG TGG AGG TCA ACG AGC AAG GAG TGG AGA TCA ACG AGC AAG GTG GAG GTC AAT GAG CAA GA TGG TAA TAG GAC ATC TCC AAG TGG TAA TAA GAC ATC TCC AAG ACT CCA GCA TAG ATG TGG ATA ACT CCA GCA TAC ATG TGG ATA GAA CTG TGA GCC GAG TCT TTA GAA CTG TGA GCT GAG TCT TTA TGG TTG ACT TGG TAG GTT TAC 3659 TGG TTG ACT TG TAG GTT TAC T TAA AAT GGT GAG TAA GA CAC 3849 T TAA AAT GGC GAG TAA GA CAC EX-20 TGC AAC AGT GGA GGA AAG CCT 1282X TGC AAC AGT GAA GGA AAG CCT EX-21 A TTT AGA AAA AAC TTG GAT CC N1303K A TTTAGA AAA AAG TTG GAT CC /3 A-PROBE AG GAC TCC ATG CCC AG INT-4 I148T EX-4 R117H EX-5 711+1G EX-7 334-M EX-7 347-M EX-7 1078DELT EX-9 A455E EX-10 F508 1507 EX-12 1898+1 Ex-13 2184delA EX-14B 2789+5G EX-16 31120+1G/A Ex-11 G542X EX-11 R560 EX-11-553/551 G551D R553X EX-11 1717-M EX-18 1152X EX-19-SENSE R1162X EX-19 INT-19 SEQ ID NO.:37 SEQ ID NO.:38 SEQ ID NO.:39 SEQ ID NO.:40 SEQ ID NO.:41 SEQ ID NO.:42 SEQ ID NO.:43 SEQ ID NO.:44 SEQ ID NO.:45 SEQ ID NO.:46 SEQ ID NO.:47 SEQ ID NO.:48 SEQ ID NO.:49 SEQ ID NO.:50 SEQ ID NO.:51 SEQ ID NO.:52 SEQ ID NO.:53 SEQ IDNO.:54 SEQ ID NO.:55 SEQ ID NO.:56 SEQ ID NO.:57 SEQ ID NO.:58 SEQ IDNO.:59 SEQ ID NO.:60 SEQ ID NO.:61 SEQ ID NO.:62 SEQ ID NO.:63 SEQ ID NO.:64 SEQ ID NO.:65 SEQ ID NO.:66 SEQ ID NO.:67 SEQ ID NO.:68 SEQ ID NO.:69 SEQ ID NO.:70 SEQ ID NO.:71 SEQ ID NO.:72 SEQ ID NO.:73 SEQ ID NO.:74 SEQ ID NO.:74 SEQ ID NO.:76 SEQ ID NO.:77 SEQ ID NO.:78 SEQ ID NO.:79 SEQ IDNO.:80 SEQ ID NO.:81 SEQ ID NO.:82 SEQ ID NO.:83CC TCA TCA CAT TGG AAT GC AG CC TCA TCA CAC TGG AAT GC AG CAA GGA GGA ACG CTC TAT CG C CAA GGA GGA ACA CTC TAT CG C ATG GGT ACA TAC TTC ATC AA A ATG GGT ACA TAA TTC ATC AA A GAA TAT TTT CCG GAG GAT GAT GAA TAT TTT CCA GAG GAT GAT CAT TGT TCT GCG CAT GGC GGT CAT TGT TCT GCC CAT GGC GGT CT CAG GGT TCT TTG TGG TG TT CT CAG GGT TC TTG TGG TGG A TT ACA GTT GTT GGC GGT TGC TGG A GTT GTT GGA GGT TGC TGG AAA GAA AAT ATC ATC TTT GGT AAA GAA AAT ATC ATT GGT GT AAA GAA AAT ATC TTT GGT GT ATA TTT GAA AGG TAT GTT CT TT ATA TTT GAA AGA TAT GTT CT TT GAA ACA AAA AAA CAA TCT TTT GAA ACA AAA AA CAA TCT TTT TTG GAA AGT GAG TAT TCC ATG TTG GAA AGT GAA TAT TCC ATG ACT TCA TCC AGA TAT GTA AAA ACT TCA TCC TCC AGG TAT GTA AAA TAT AGT TCT TGG AGA AGG TGG TAT AGT TCT TTG AGA AGG TTA GCA AGG TGA ATA ACT TCT TTA GCA ACG TGA ATA ACT GAG TGG AGG TCA ACG AGC AAG GAG TGG AGA TCA ACG AGC AAG GTG GAG GTC AAT GAG CAA GA TGG TAA TAG GAC ATC TCC AAG TGG TAA TAA GAC ATC TCC AAG ACT GCA TAG ATG TGG ATA ACT CCA GCA T AC ATG TGG ATA GAA CTG TGA GCC GAG TCT TTA GAA CTG TGA GCT GAG TCT TTA TGG TTG ACT TGG TAG GTT TAC 3659 TGG TTG ACT TG TAG GTT TAC T TAA AAT GGT GAG TAA GA CAC 3849 T TAA AAT GGC GAG TAA GA CAC EX-20 TGC AAC AGT GGA GGA AAG CCT 1282X TGC AAC AGT GAA GGA AAG CCT EX-21 A TTT AGA AAA AAC TTG GAT CC N1303K A TTTAGA AAA AAG TTG GAT CC / 3 A-PROBE AG GAC TCC ATG CCC AG INT- 4 I148T EX-4 R117H EX-5 711 + 1G EX-7 334-M EX-7 347-M EX-7 1078DELT EX-9 A455E EX-10 F508 1507 EX-12 1898 + 1 Ex-13 2184delA EX-14B 2789 + 5G EX-16 31120 + 1G / A Ex-11 G542X EX-11 R560 EX-11-553 / 551 G551D R553X EX-11 1717-M EX-18 1152X EX-19-SENSE R1162X EX-19 INT-19 SEQ ID NO.:37 SEQ ID NO.:38 SEQ ID NO.:39 SEQ ID NO.:40 SEQ ID NO.:41 SEQ ID NO.:42 SEQ ID NO.:43 SEQ ID NO.:44 SEQ ID NO.:45 SEQ ID NO.:46 SEQ ID NO.:47 SEQ ID NO.:48 SEQ ID NO.:49 SEQ ID NO.:50 SEQ ID NO.:51 SEQ ID NO.:52 SEQ ID NO. : 53 SEQ IDNO.:54 SEQ ID NO.:55 SEQ ID NO.:56 SEQ ID NO.:57 SEQ ID NO.:58 SEQ IDNO.:59 SEQ ID NO.:60 SEQ ID NO.:61 SEQ ID NO.:62 SEQ ID NO .: 63 SEQ ID NO.:64 SEQ ID NO.:65 SEQ ID NO.:66 SEQ ID NO.:67 SEQ ID NO.:68 SEQ ID NO.:69 SEQ ID NO.:70 SEQ ID NO .: 71 SEQ ID NO.:72 SEQ ID NO.:73 SEQ ID NO.:74 SEQ ID NO.:74 SEQ ID NO.:76 SEQ ID NO.:77 SEQ ID NO.:78 SEQ ID NO.:79 SEQ IDNO.:80 SEQ ID NO.:81 SEQ ID NO.:82 SEQ ID NO.:83
40 200538552 該雜交緩衝液係在單一及/或多重雜交分析中被最佳化, 且係組成如下(最終濃度):1. 125M四甲基氯化銨(TMAC), 18·75ιηΜ Tris-HCl (ΡΗ8·0),0.75mM EDTA (ΡΗ8·0)及 0.0375% SDS。包含緩衝液及單股DNA的1〇// 1雜交混合物 被加在晶片表面,且於55它培養15分鐘。相較於正常數 小η守的雜父時間而言,這是一個短暫的雜交時間,因為較 長的雜交時間導致產生無法控制的過量雜交。該晶片以1Χ TMAC緩衝液清洗三次,而後覆蓋一乾淨的蓋子,及利用 _ BAS影像系統進行分析。分析影像以決定每一探針的身分 。結果顯示在下列圖1及圖2。 突變中的每一對偶基因係根據以下分析。首先,產生 自雜交對偶基因的信號係經由下列校正: (·)對偶基因A (以擴增子標定)的信號=經標定之擴增子一 雜合的原始信號減去負控制組(背景值)的原始計數 (11)對偶基因B(未標定的擴增子)的信號=未標定之擴增 子雜口的屑、始信號減去負控制組(背景值)之原始計畫文 φ 而後計算對偶基因的比例: =偶比例=對偶基因A的信號/對偶基因B的信號 當⑴值小於或等於0時,其被調整為〇1以避免產生 顯示為::基夕因比例>2係被記為與對偶基因A為同源性( 基因‘多型性),當對偶比例<0.5時係被記為與對偶 為间源性(野生型)。對偶比例為0 8至12時係被 41 200538552 記為異源性。數值落於這些門檻數值之間者,則被視為模 糊不清的,該分析需重複操作。 實施例11 :多重病人檢體的篩選-一以點潰分析法對 hMAP的逐一比較 取得一數量的病人檢體,並放大用於同時篩選。該放 大反應的方法及探針設計係如前述。經過放大反應之後, 檢體的分析技術係對2 6 CFTR突變進行比較。一組檢體係 利用既有的點潰雜交方法進行分析,而相同檢體另利用本 發明的方法及反應試劑進行分析。收集每一病人檢體的分 析結果且比較之。發現在二種偵測方法中具有1 00%—致性 。對於每一個突變,檢體數目確認為正值者被列於表V中 〇 表V :受測檢體的比較 檢體係經由點潰法及本發 突變 #正值 G85E 11 G85E/621+1G 8 621+1G>T 11 621+lG>T/delF50 8 2 R117H 19 R117H/delF508 1 I148T 48 delF508 58 1507 11 delF508/R560 1 G542X 44 G551D 11 R553X 15 1717-1G>A 14 測 檢5 2 所矣2 法 方 之 述值 所#tn 明 3 11 4 1140 200538552 The hybridization buffer was optimized for single and / or multiple hybridization analysis, and the composition was as follows (final concentration): 1. 125M tetramethylammonium chloride (TMAC), 18.75 μM Tris-HCl ( (PQ8 · 0), 0.75mM EDTA (PQ8 · 0) and 0.0375% SDS. A 10 // 1 hybridization mixture containing buffer and single-stranded DNA was added to the wafer surface, and it was incubated at 55 for 15 minutes. This is a short hybridization time compared to the normal number of heterosexuals with small η guards, because longer hybridization times lead to uncontrolled overhybridization. The wafer was washed three times with 1X TMAC buffer, then covered with a clean lid, and analyzed using the BAS imaging system. Analyze the images to determine the identity of each probe. The results are shown in Figures 1 and 2 below. Each dual gene line in the mutation was analyzed according to the following. First, the signals generated from the hybridized dual genes were corrected as follows: (·) Signals from dual gene A (calibrated with amplicons) = calibrated amplicon-hybrid original signal minus negative control group (background value) ) Original count (11) Signal of dual gene B (uncalibrated amplicon) = Uncalibrated amplicon miscellaneous debris, start signal minus original plan text φ of negative control group (background value), and then Calculate the ratio of dual genes: = dual ratio = signal of dual gene A / signal of dual gene B. When the value of ⑴ is less than or equal to 0, it is adjusted to 〇1 to avoid the display. Lines are described as homologous to the dual gene A (gene's polymorphism), and when the ratio of duality is < 0.5, the lines are recorded as intergenic (wild-type) with the duality. When the dual ratio is 0 8 to 12, it is recorded as heterogeneous by 41 200538552. Values falling between these thresholds are considered ambiguous and the analysis needs to be repeated. Example 11: Screening of multiple patient specimens-one-by-one comparison of hMAP by point rupture analysis method A number of patient specimens were obtained and enlarged for simultaneous screening. The amplification reaction method and probe design are as described above. After the amplification reaction, the analysis technique of the specimen is to compare the 2 6 CFTR mutation. One set of test systems was analyzed using the existing point-blot hybridization method, while the same sample was also analyzed using the method and reaction reagent of the present invention. The analysis results of each patient specimen were collected and compared. It was found to be 100% consistent in the two detection methods. For each mutation, those with a positive number of specimens are listed in Table V. Table V: The comparison test system of the test specimens via the point break method and the mutation #Positive values G85E 11 G85E / 621 + 1G 8 621 + 1G > T 11 621 + 1g > T / delF50 8 2 R117H 19 R117H / delF508 1 I148T 48 delF508 58 1507 11 delF508 / R560 1 G542X 44 G551D 11 R553X 15 1717-1G &A; A 14 Test 5 2 The value of French law # tn Ming 3 11 4 11
11 IX 24 1 5 5 15 4 11 11 11 42 200538552 R560T 3849+10kbC>T W1282X N1303K mPCR-WT 711+1G>T 711+1G>T/621+ R334W R347P 1078delT A455E 1898+1G>A 2184delA 2789+5G>A 3120+lg〉A R1162X 3569delC D1152 mPCR-WT 總數 5 3 1 2 5 3 3 5 7 11811 IX 24 1 5 5 15 4 11 11 42 200538552 R560T 3849 + 10kbC > T W1282X N1303K mPCR-WT 711 + 1G > T 711 + 1G > T / 621 + R334W R347P 1078delT A455E 1898 + 1G > A 2184delA 2789 + 5G > A 3120 + lg〉 A R1162X 3569delC D1152 mPCR-WT Total 5 3 1 2 5 3 3 5 7 118
9 3 11 1X 11 G 8 4 0 0 8 3 1X 0/^ 11 2 IX 11 7 11 11 ο ο ο ο 1X II 1X 11 80 9 6 6 7 8 031940081 6 0 3 3648213112323228589 應瞭解,本文所使用的術語、表達方式以及實施例係作為 例示,而非作為限制,且程序及方法可以以任何順序進行 之,除非已指明步驟的順序。本發明係定義於下面之申請 專利範圍中,並包括與申請專利範圍所有的均等者。 【圖式簡單說明】 圖1係表示29個不同CFTR突變的雜交結果,其中較 小的開放性橫條顯示突變雜交,且其中對於“正常型”的雜 交係顯示較大黑色的橫條(例如:EX-1 0具有一高程度的突 變雜交)。 圖2係表示29個不同CFTR突變的雜交結果,該突變 係與圖1所示不同。 圖3係表示一經由校正的陣列影像負控制組攜帶者的9 3 11 1X 11 G 8 4 0 0 8 3 1X 0 / ^ 11 2 IX 11 7 11 11 ο ο ο ο 1X II 1X 11 80 9 6 6 7 8 031940081 6 0 3 3648213112323228589 It should be understood that the terms used in this article , Expressions, and examples are by way of illustration, not limitation, and procedures and methods can be performed in any order, unless the order of steps has been specified. The present invention is defined in the following patent application scope and includes all equivalents to the patent application scope. [Schematic description] Figure 1 shows the hybridization results of 29 different CFTR mutations. The smaller open bars show mutant crosses, and the "normal" hybrid lines show larger black bars (for example, : EX-1 0 has a high degree of mutant crosses). Fig. 2 shows the results of hybridization of 29 different CFTR mutations, which are different from those shown in Fig. 1. FIG. 3 shows the carrier of a negative control group of the array image after correction.
43 200538552 背景圖像。43 200538552 Background image.
44 200538552 序歹fj表 <110> Hashmi, Ghazala Seul, Michael44 200538552 Ordering fj table < 110 > Hashmi, Ghazala Seul, Michael
<12〇>多型性的雜交中介分析 <130>hMAP <150 60/470.806 <151> 2003-05-15 <160> 83 <170> FastSEQ for Windows Version 4.0 <210> 1 <211> 19 <212> DNA <213>人工序列 <220 <223>人工引子 <400> 1 gtcaagccgt gttctagat 19< 12〇 > Polymorphic hybridization analysis < 130 > hMAP < 150 60 / 470.806 < 151 > 2003-05-15 < 160 > 83 < 170 > FastSEQ for Windows Version 4.0 < 210 > 1 < 211 > 19 < 212 > DNA < 213 > artificial sequence < 220 < 223 > artificial primer < 400 > 1 gtcaagccgt gttctagat 19
<210>2 <211> 23 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 2 gttgtataat ttataacaat agt 23< 210 > 2 < 211 > 23 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 2 gttgtataat ttataacaat agt 23
<210>3 <211 >20 <212>DNA <213>人工序列 <220> <223>人工引子 <400> 3 acttcaatag ctcagccttc 20 <210>4 <211 >23 <212> DNA <213>人工序列 200538552 <220 <223>人工引子 <400> 4 tatggtacat tacctgtatt ttg< 210 > 3 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 3 acttcaatag ctcagccttc 20 < 210 > 4 < 211 > 23 < 212 > DNA < 213 > artificial sequence 200538552 < 220 < 223 > artificial primer < 400 > 4 tatggtacat tacctgtatt ttg
<210> 5 <211> 18 <212> DNA <213>入工序列 <220> <223>人工引子 <400> 5 tggtgacagc ctcttctt <210> 6 <211> 20 <212> DNA <213>人工序列 <220> <223>人項子 <400> 6 gaactacctt gcctgctcca< 210 > 5 < 211 > 18 < 212 > DNA < 213 > entry sequence < 220 > < 223 > artificial primer < 400 > 5 tggtgacagc ctcttctt < 210 > 6 < 211 > 20 < 212 > DNA < 213 > Artificial sequence < 220 > < 223 > Human item < 400 > 6 gaactacctt gcctgctcca
<210> 7 <211>21 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 7 tctccttttg gatacctaga t< 210 > 7 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 7 tctccttttg gatacctaga t
<210>8 <211>21 <212〉DNA <213>人工序列 <220> <223>人工引子 <400> 8 tgagcattat aagtaaggta t< 210 > 8 < 211 > 21 < 212> DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 8 tgagcattat aagtaaggta t
<210〉9 <211>21 <212> DNA <213>人工序列 200538552 <220> <223>人工引子 <400> 9 aggtagcagc tatttttatg g 21 <210> 10 <211> 18 <212> ΠΝΑ <213>人工序列 <220> <223>人工引子 <400> 10 atctggtact aaggacag 18< 210> 9 < 211 > 21 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > artificial primer < 400 > 9 aggtagcagc tatttttatg g 21 < 210 > 10 < 211 > 18 < 212 > ΠΝΑ < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 10 atctggtact aaggacag 18
<210> 11 <211>20 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 11 tctttggttg tgctgtggct 20< 210 > 11 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 11 tctttggttg tgctgtggct 20
<210> 12 <211>20 <212> DNA <213>人工序列 <220> <223>人工引子 <400〉12 acaatacata caaacatagt 20< 210 > 12 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400> 12 acaatacata caaacatagt 20
<210> 13 <211>21 <212> DNA <213>人工序列 <220> <223>人工引子 <400〉13 cttctgctta ccatatttga c 21< 210 > 13 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400> 13 cttctgctta ccatatttga c 21
<210> 14 <211>20 <212>DNA <213>&工序列 -3- 200538552 <220> <223>人工引子 <400〉14 taatacagac atacttaacg <210> 15 <211> 20 <212> DNA <13>:人工序列 <220> <223>人工引子 <400> 15 ggagaaggag aaggaagagt< 210 > 14 < 211 > 20 < 212 > DNA < 213 > & engineering sequence-3- 200538552 < 220 > < 223 > artificial primer < 400〉 14 taatacagac atacttaacg < 210 > 15 < 211 > 20 < 212 > DNA < 13 >: artificial sequence < 220 > < 223 > artificial primer < 400 > 15 ggagaaggag aaggaagagt
<210> 16 <211> 21 <212> DNA <213>|人工序^[ <220> <223>人工引子 <400> 16 atctatgaga aggaaagaag a <21〇> 17 <211> 20 <212> DNA <213>人工序列 <220> — <223>人工引子 <400> 17 ggccaaatga ctgtcaaaga< 210 > 16 < 211 > 21 < 212 > DNA < 213 > | Human Procedure ^ [< 220 > < 223 > Artificial primers < 400 > 16 atctatgaga aggaaagaag a < 21〇 > 17 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > — < 223 > artificial primer < 400 > 17 ggccaaatga ctgtcaaaga
<210> 18 <211 >20 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 18 tgcttcaggc tactgggatt <210> 19 <211 >20 <212>DNA <213>人工序列 200538552 <220> <223>人工引子 <400> 19 cggcgatgtt ttttctggag <210> 20 <211> 20 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 20 tacaaatgag atccttaccc< 210 > 18 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 18 tgcttcaggc tactgggatt < 210 > 19 < 211 > 20 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > artificial primer < 400 > 19 cggcgatgtt ttttctggag < 210 > 20 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > Artificial primers < 400 > 20 tacaaatgag atccttaccc
<210> 21 <211> 20 <212> DNA <213>人工序刿 <220> <223>人工引子 <400 21 agcttcctat gacccggata< 210 > 21 < 211 > 20 < 212 > DNA < 213 > human process 刿 < 220 > < 223 > artificial primer < 400 21 agcttcctat gacccggata
<210> 22 <211> 20 <212〉DNA <213>人工序列 <220> <223>人工引无 <400〉22 tgtgatgaag gccaaaaatg <210> 23 <211 >20 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 23 tgttctcagt tttcctggat <210> 24 <211>20 <212> DNA <213>人工序列 200538552 <220> <223>,人工引子 <400> 24 ctcttctagt tggcatgctt <210> 25 <211> 20 <212> DNA <213>.人工序列 <220> <223>人工引子 <400〉25 cagattgagc atactaaaag <210 26 <211> 20 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 26 acatgaatga catttacagc< 210 > 22 < 211 > 20 < 212> DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400> 22 tgtgatgaag gccaaaaatg < 210 > 23 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 23 tgttctcagt tttcctggat < 210 > 24 < 211 > 20 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 >, artificial primers < 400 > 24 ctcttctagt tggcatgctt < 210 > 25 < 211 > 20 < 212 > DNA < 213 >. artificial sequence < 220 > < 223 > artificial primer < 400〉 25 cagattgagc atactaaaag < 210 26 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 26 acatgaatga catttacagc
<210> 27 <211> 21 <212> DNA <213>人工序列 <220> <223>人工引子 <400〉27 aatcattcag tgggtataag c <210〉28 <211> 21 <212> DNA <213>人工序列 <220> <223>人工引子 <400> 28 cctcctccct gagaatgttg g <210> 29 <211 >20 <212> DNA <213>人工序列 200538552 <220> <223>人工引子 <400 29 ctggatcagg gaagagaagg <210〉30 <211>20 <212> DNA <213>人工序列 <220> <223>|人工引子 <400> 30 tccttttgct cacctgtggt <210>31 <211>20 <212> DNA <213>人工序列 <220> <223>;人工引子 <400> 31 tgatggtaag tacatgggtg <210> 32 <211>20 <212>DNA <213>人工序列 <220> <223>人工引子 <400 32 caaaagtacc tgttgctcca <210〉33 <211>21 <212>DNA <213>人工序列 <220> <223〉人工探針 <400> 33 atgttctatg gaatcttttt a <210〉34 <211>21 <212> DNA <213>人工序列 200538552 <220> <223>人工探針 <400> 34 atgttctatg aaatcttttt a -列 序 nah 3521DN人 >>>> 0 12 3 τ— τ— ^— τ— 2 2 2 2 <220> <223〉人工探針 <400> 35 tataagaagg taatacttcc t< 210 > 27 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400〉 27 aatcattcag tgggtataag c < 210〉 28 < 211 > 21 <; 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 > 28 cctcctccct gagaatgttg g < 210 > 29 < 211 > 20 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > Artificial primers < 400 29 ctggatcagg gaagagaagg < 210〉 30 < 211 > 20 < 212 > DNA < 213 > Artificial sequence < 220 > < 223 > | Artificial primer <; 400 > 30 tccttttgct cacctgtggt < 210 > 31 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 >; artificial primer < 400 > 31 tgatggtaag tacatgggtg < 210 > 32 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial primer < 400 32 caaaagtacc tgttgctcca < 210〉 33 < 211 > 21 < 212 > DNA < 213 > Artificial sequence < 220 > < 223> artificial probe < 400 > 33 atgttctatg gaatcttttt a < 2 10> 34 < 211 > 21 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > artificial probe < 400 > 34 atgttctatg aaatcttttt a -column order nah 3521DN person > > > > 0 12 3 τ— τ— ^ — τ— 2 2 2 2 < 220 > < 223> Artificial probe < 400 > 35 tataagaagg taatacttcc t
<210> 36 <211> 21 <212> DNA <213>人工序列 <220〉一 <223>人工探針 <400〉36 tataagaagt taatacttcc t <2i〇> 37 <211> 21 <212> DNA <213>人工序列 <220> <223〉人工探針 <400> 37 cctcatcaca ttggaatgca g <210> 38 <211> 21 <212〉DNA <213>人工序列 <220> <223>人工探針 <400〉38 cctcatcaca ctggaatgca g <210〉39 <211>21 <212> DNA <213>人工序列 200538552 <220> <223> ;人工探針 <400> 39 caaggaggaa cgctctatcg c< 210 > 36 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220〉-< 223 > artificial probe < 400> 36 tataagaagt taatacttcc t < 2i〇 > 37 < 211 > 21 < 212 > DNA < 213 > Artificial sequence < 220 > < 223〉 Artificial probe < 400 > 37 cctcatcaca ttggaatgca g < 210 > 38 < 211 > 21 < 212> DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400〉 38 cctcatcaca ctggaatgca g < 210〉 39 < 211 > 21 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 >; Artificial probe < 400 > 39 caaggaggaa cgctctatcg c
<210> 40 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 40 caaggaggaa cactctatcg c <210>41 <211> 21 <212> DNA <213>人工序列 <220> <223>人工探針 <400 41 atgggtacat acttcatcaa a< 210 > 40 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 40 caaggaggaa cactctatcg c < 210 > 41 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 41 atgggtacat acttcatcaa a
<210> 42 <211> 21 <212> DNA <213>人發列 <220 <223>人工探針 <400〉42 atgggtacat aattcatcaa a <210〉43 <211>21 <212〉DMA <213>人工序列 <220> <223〉人工採針 <400> 43 gaatattttc cggaggatga t< 210 > 42 < 211 > 21 < 212 > DNA < 213 > human hair train < 220 < 223 > artificial probe < 400〉 42 atgggtacat aattcatcaa a < 210> 43 < 211 > 21 < 212> DMA < 213 > Artificial sequence < 220 > < 223> Artificial needle picking < 400 > 43 gaatattttc cggaggatga t
<210> 44 <211>21 <212> DNA <213>人工序列 200538552 <220> <223>人工探針 <400 44 gaatattttc cagaggatga t 21 <210> 45 <211>21 <212〉DNA <213>人工序列 <220> <223>人工探針 <400〉45 cattgttctg cgcatggcgg t 21 <210〉46 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 46 cattgttctg cccatggcgg t 21< 210 > 44 < 211 > 21 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > artificial probe < 400 44 gaatattttc cagaggatga t 21 < 210 > 45 < 211 > 21 < 212> DNA < 213 > Artificial Sequence < 220 > < 223 > Artificial Probe < 400> 45 cattgttctg cgcatggcgg t 21 < 210> 46 < 211 > 21 < 212 > DNA < 213 > Artificial sequence < 220 > < 223 > artificial probe < 400 > 46 cattgttctg cccatggcgg t 21
<210> 47 <211>21 <212> DNA <213>人工序列 丨 <220> <223>丨人工探針 <400> 47 ctcagggttc tttgtggtgt t 21 <210 48 <211> 20 <212>DNA <213>人工序列— <220> <223〉人工探針 <400> 48 ctcagggttc ttgtggtgtt 20< 210 > 47 < 211 > 21 < 212 > DNA < 213 > artificial sequence 丨 < 220 > < 223 > 丨 artificial probe < 400 > 47 ctcagggttc tttgtggtgt t 21 < 210 48 < 211 > 20 < 212 > DNA < 213 > artificial sequence — < 220 > < 223> artificial probe < 400 > 48 ctcagggttc ttgtggtgtt 20
<210> 49 <211> 21 <212> DNA <213>人工序列 10 200538552 <220 <223>,人工探針 <400> 49 acagttgttg gcggttgctg g <210> 50 <211> 21 <212> DNA <213>人工序列 <220> <223'&工探針 <400〉50 acagttgttg gaggttgctg g <210> 51 <211> 21 <212> DNA <213>人工序列 <220> <223>人工探針 <400〉 51 aaagaaaata tcatctttgg t <210> 52 <211> 20 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 52 aaagaaaata tcattggtgt <210> 53 <211>20 <212〉DNA <213>人工序列 <220> <223>;人工探針 — <400> 53 aaagaaaata tctttggtgt <210〉 54 <211 >22 <212>DNA <213>人工序列 200538552 <220> <223>人工探針 <400〉54 atatttgaaa ggtatgttct tt 22 <210〉55 <211>22 <212〉DNA <213>人工序列 <220> <223>人工探針 <400> 55< 210 > 49 < 211 > 21 < 212 > DNA < 213 > artificial sequence 10 200538552 < 220 < 223 >, artificial probe < 400 > 49 acagttgttg gcggttgctg g < 210 > 50 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 '& engineering probe < 400〉 50 acagttgttg gaggttgctg g < 210 > 51 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400> 51 aaagaaaata tcatctttgg t < 210 > 52 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > <; 223 > artificial probe < 400 > 52 aaagaaaata tcattggtgt < 210 > 53 < 211 > 20 < 212> DNA < 213 > artificial sequence < 220 > < 223 >; artificial probe — < 400 > 53 aaagaaaata tctttggtgt < 210> 54 < 211 > 22 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > artificial probe < 400> 54 atatttgaaa ggtatgttct tt 22 < 210 > 55 < 211 > 22 < 212> DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 5 5
atatttgaaa gatatgttct tt 22 <210〉56 <211> 21 <212〉D|iA <213> Λ工序列 <220> r <223〉人工探針 <400〉56 gaaacaaaaa aacaatcttt t 21atatttgaaa gatatgttct tt 22 < 210〉 56 < 211 > 21 < 212〉 D | iA < 213 > Λ sequence < 220 > r < 223> artificial probe < 400〉 56 gaaacaaaaa aacaatcttt t 21
<210> 57 <211> 20 <212> DNA <213>人工序列 <220>< 210 > 57 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 >
<223>人工探針 <400 57 gaaacaaaaa acaatctttt 20 <210> 58 <211>21 <212> DNA <213>人工序列 <220> <223>.人工探針 <400〉58 ttggaaagtg agtattccat g 21< 223 > Artificial probe < 400 57 gaaacaaaaa acaatctttt 20 < 210 > 58 < 211 > 21 < 212 > DNA < 213 > Artificial sequence < 220 > < 223 >. Artificial probe < 400 〉 58 ttggaaagtg agtattccat g 21
<210> 59 <211>21 <212> DNA <213>人工序列 12 200538552 <220> <223〉人工探針 <400 59 ttggaaagtg aatattccat g 21 <210> 60 <211> 21 <212> DNA <21人工序列 一 <220> <223〉人工_土 -<400> 60< 210 > 59 < 211 > 21 < 212 > DNA < 213 > artificial sequence 12 200538552 < 220 > < 223> Artificial probe < 400 59 ttggaaagtg aatattccat g 21 < 210 > 60 < 211 > 21 < 212 > DNA < 21 artificial sequence 1 < 220 > < 223> artificial_soil- < 400 > 60
acttcatcca gatatgtaaa a 21acttcatcca gatatgtaaa a 21
<210> 61 <211> 21 <212> DNA <213>人工序列 <220> <223〉人工探針 <400〉61 acttcatcca ggtatgtaaa a 21< 210 > 61 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223〉 artificial probe < 400〉 61 acttcatcca ggtatgtaaa a 21
<210> 62 <211> 21 <212> DNA <213>人工序列 <220>< 210 > 62 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 >
<223〉人工探i十 <400> 62 tatagttctt ggagaaggtg g 21 <210> 63 <211> 21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 63 tatagttctt tgagaaggtg g 21< 223> Artificial Probe < 400 > 62 tatagttctt ggagaaggtg g 21 < 210 > 63 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Artificial Probe <; 400 > 63 tatagttctt tgagaaggtg g 21
<210> 64 <211> 21 <212〉DNA <213>人工序列 13 200538552 、220> <223>人工择針 <4〇〇> 64 tctttagcaa ggtgaataac t< 210 > 64 < 211 > 21 < 212> DNA < 213 > artificial sequence 13 200538552, 220 > < 223 > artificial needle selection < 4〇〇 > 64 tctttagcaa ggtgaataac t
<210>65 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 65 tctttagcaa cgtgaataac t <210 66 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 _ <400> 66 gagtggaggt caacgagcaa g <210> 67 <211> 21 <212> DNA <213>人工序列 <220> <223〉人工探針 <400〉67 gagtggagat caacgagcaa g <210 68 <211> 20 <212> DNA <213>人工序列 <220> <223>人工探針 <400 68 gtggaggtca atgagcaaga <210〉69 <211>21 <212> DMA <213>人工序列 200538552 <220> <223>人工探針 <400> 69 tggtaatagg acatctccaa g 21 <210> 70 <211> 21 <212> DNA <213>,人工序列 <220 <223>人工释針 <400> 70 tggtaataag acatctccaa g 21 <210>71 <211>21 <212> DNA <213>人工序列 <220> <223〉丨人工释針 <400> 71 actccagcat agatgtggat a 21 <210> 72 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 72 actccagcat acatgtggat a 21 <210> 73 <211> 21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 73 gaactgtgag ccgagtcttt a 21 <210 74·< 210 > 65 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 65 tctttagcaa cgtgaataac t < 210 66 < 211 > 21 <21; 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe_ < 400 > 66 gagtggaggt caacgagcaa g < 210 > 67 < 211 > 21 < 212 > DNA < 213 > artificial Sequence < 220 > < 223> artificial probe < 400> 67 gagtggagat caacgagcaa g < 210 68 < 211 > 20 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe Needle < 400 68 gtggaggtca atgagcaaga < 210> 69 < 211 > 21 < 212 > DMA < 213 > Artificial Sequence 200538552 < 220 > < 223 > Artificial Probe < 400 > 69 tggtaatagg acatctccaa g 21 < 210 > 70 < 211 > 21 < 212 > DNA < 213 >, artificial sequence < 220 < 223 > artificial release needle < 400 > 70 tggtaataag acatctccaa g 21 < 210 > 71 < 211 > 21 < 212 > DNA < 213 > Artificial sequence < 220 > < 223〉 丨 Artificial release needle < 400 > 71 actccagcat agatgt ggat a 21 < 210 > 72 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 72 actccagcat acatgtggat a 21 < 210 > 73 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 73 gaactgtgag ccgagtcttt a 21 < 210 74 ·
<211>21 <212> DNA <213>人工序列 15- 200538552 <220〉. <223>人工探針 <400 74 gaactgtgag ctgagtcttt a <210>75 <211>21 <212> hnja _ <213>人工序到 <220> <223>人工探針 <400> 75 tggttgactt ggtaggttta c <210> 76 <211>20 <212> ΠΝΑ <213〉&工序列 <220> <223>人工探針 <400〉76 tggttgactt gtaggtttac< 211 > 21 < 212 > DNA < 213 > Artificial Sequence 15- 200538552 < 220〉. < 223 > Artificial Probe < 400 74 gaactgtgag ctgagtcttt a < 210 > 75 < 211 > 21 < 212 > hnja _ < 213 > human process to < 220 > < 223 > artificial probe < 400 > 75 tggttgactt ggtaggttta c < 210 > 76 < 211 > 20 < 212 > ΠΝΑ < 213> & Working sequence < 220 > < 223 > Artificial probe < 400> 76 tggttgactt gtaggtttac
<210>77 <211>21 <212> DNA <213> AX^IJ <220> __ <223>么工探針 <400 77 ttaaaatggt gagtaagaca c< 210 > 77 < 211 > 21 < 212 > DNA < 213 > AX ^ IJ < 220 > __ < 223 > Modular probe < 400 77 ttaaaatggt gagtaagaca c
<210> 78 <211>21 <212> DNA <213>人工序列 <220> <223>人工探針 <400> 78 ttaaaatggc gagtaagaca c .< 210 > 78 < 211 > 21 < 212 > DNA < 213 > artificial sequence < 220 > < 223 > artificial probe < 400 > 78 ttaaaatggc gagtaagaca c.
<210> 79 <211>21 <212> DNA <213>人工序列 200538552 <220> <223>人:]^罙針 <400〉79 tgcaacagtg gaggaaagcc t 21 <210> 80 <211> 21 <212> DNA _ <213>人工序列―~ <220 <223>人工探針 <400> 80< 210 > 79 < 211 > 21 < 212 > DNA < 213 > artificial sequence 200538552 < 220 > < 223 > human:] ^ 罙 针 &400; 79 tgcaacagtg gaggaaagcc t 21 < 210 > 80 < 211 > 21 < 212 > DNA _ < 213 > artificial sequence-~ < 220 < 223 > artificial probe < 400 > 80
tgcaacagtg aaggaaagcc t 21tgcaacagtg aaggaaagcc t 21
<210> 81 <211> 21 <212> DNA <213>人工序列 — <220> <223>人工探針 <400> 81 atttagaaaa aacttggatc c 21 <210> 82 <211> 21 <212〉DNA <213〉人工序列 <220>< 210 > 81 < 211 > 21 < 212 > DNA < 213 > artificial sequence — < 220 > < 223 > artificial probe < 400 > 81 atttagaaaa aacttggatc c 21 < 210 > 82 < 211 > 21 < 212〉 DNA < 213> artificial sequence < 220 >
<223>人工探針 <400> 82 atttagaaaa aagttggatc c 21 <210> 83 <211> 16 <212> DNA <213>人工@列 <220> <223>人工探針 — <400> 83 aggactccat gcccag 16 -17 -< 223 > Artificial probe < 400 > 82 atttagaaaa aagttggatc c 21 < 210 > 83 < 211 > 16 < 212 > DNA < 213 > artificial @ 列 < 220 > < 223 > artificial probe— < 400 > 83 aggactccat gcccag 16 -17-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/015224 WO2004104172A2 (en) | 2003-05-15 | 2004-05-17 | Hybridization-mediated analysis of polymorphisms |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200538552A true TW200538552A (en) | 2005-12-01 |
Family
ID=52350468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093117905A TW200538552A (en) | 2004-05-17 | 2004-06-21 | Hybridization-mediated analysis of polymorphisms |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200538552A (en) |
-
2004
- 2004-06-21 TW TW093117905A patent/TW200538552A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021200925B2 (en) | Assays for single molecule detection and use thereof | |
US7771939B2 (en) | Correcting an assay image of an array of signals generated from a multiplexed hybridization-mediated assay | |
EP1124990B1 (en) | Complexity management and analysis of genomic dna | |
US7108976B2 (en) | Complexity management of genomic DNA by locus specific amplification | |
US10415081B2 (en) | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection | |
US8129120B2 (en) | Methods for genetic analysis of DNA to detect sequence variances | |
US20170096713A1 (en) | Applications of single molecule sequencing | |
CA2409774A1 (en) | Methods for genetic analysis of dna to detect sequence variances | |
EP1723261A1 (en) | Detection of strp, such as fragile x syndrome | |
US20040014086A1 (en) | Regulome arrays | |
US20040023237A1 (en) | Methods for genomic analysis | |
US20090061440A1 (en) | Method for amplifying plural nucleic acid sequences for discrimination | |
TW200538552A (en) | Hybridization-mediated analysis of polymorphisms | |
US7659054B1 (en) | Methods for genetic analysis of DNA to detect sequence variances | |
KR20120038333A (en) | Novel egr2 snps related to bipolar disorder, microarrays and kits comprising them for diagnosing bipolar disorder | |
CA2572176A1 (en) | Probe optimization methods | |
JPWO2005090565A1 (en) | DNA array and single nucleotide polymorphism detection method | |
US20100285970A1 (en) | Methods of sequencing nucleic acids |